<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-03-11T00:56:05Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8031749" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8031749</identifier>
        <datestamp>2021-04-15</datestamp>
        <setSpec>ploscomp</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS Comput Biol</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS Comput Biol</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">ploscomp</journal-id>
              <journal-title-group>
                <journal-title>PLoS Computational Biology</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">1553-734X</issn>
              <issn pub-type="epub">1553-7358</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8031749</article-id>
              <article-id pub-id-type="pmcid">PMC8031749</article-id>
              <article-id pub-id-type="pmc-uid">8031749</article-id>
              <article-id pub-id-type="pmid">33780443</article-id>
              <article-id pub-id-type="pmid">33780443</article-id>
              <article-id pub-id-type="publisher-id">PCOMPBIOL-D-20-00822</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pcbi.1008837</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Viral Diseases</subject>
                        <subj-group>
                          <subject>Covid 19</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Pandemics</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Mathematical and Statistical Techniques</subject>
                    <subj-group>
                      <subject>Statistical Methods</subject>
                      <subj-group>
                        <subject>Forecasting</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Mathematics</subject>
                    <subj-group>
                      <subject>Statistics</subject>
                      <subj-group>
                        <subject>Statistical Methods</subject>
                        <subj-group>
                          <subject>Forecasting</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Computer and Information Sciences</subject>
                  <subj-group>
                    <subject>Artificial Intelligence</subject>
                    <subj-group>
                      <subject>Machine Learning</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                    <subj-group>
                      <subject>Virus Testing</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Physical Sciences</subject>
                  <subj-group>
                    <subject>Mathematics</subject>
                    <subj-group>
                      <subject>Applied Mathematics</subject>
                      <subj-group>
                        <subject>Algorithms</subject>
                        <subj-group>
                          <subject>Machine Learning Algorithms</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Research and Analysis Methods</subject>
                  <subj-group>
                    <subject>Simulation and Modeling</subject>
                    <subj-group>
                      <subject>Algorithms</subject>
                      <subj-group>
                        <subject>Machine Learning Algorithms</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Computer and Information Sciences</subject>
                  <subj-group>
                    <subject>Artificial Intelligence</subject>
                    <subj-group>
                      <subject>Machine Learning</subject>
                      <subj-group>
                        <subject>Machine Learning Algorithms</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and places</subject>
                  <subj-group>
                    <subject>Geographical locations</subject>
                    <subj-group>
                      <subject>North America</subject>
                      <subj-group>
                        <subject>United States</subject>
                        <subj-group>
                          <subject>New York</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Epidemiology</subject>
                    <subj-group>
                      <subject>Infectious Disease Epidemiology</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Medical Conditions</subject>
                    <subj-group>
                      <subject>Infectious Diseases</subject>
                      <subj-group>
                        <subject>Infectious Disease Epidemiology</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Pandemic velocity: Forecasting COVID-19 in the US with a machine learning &amp; Bayesian time series compartmental model</article-title>
                <alt-title alt-title-type="running-head">Forecasting COVID-19 with Bayesian and machine learning models</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7597-7359</contrib-id>
                  <name>
                    <surname>Watson</surname>
                    <given-names>Gregory L.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Formal analysis</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <role content-type="https://casrai.org/credit/">Visualization</role>
                  <role content-type="https://casrai.org/credit/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-5502-1464</contrib-id>
                  <name>
                    <surname>Xiong</surname>
                    <given-names>Di</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6829-703X</contrib-id>
                  <name>
                    <surname>Zhang</surname>
                    <given-names>Lu</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6309-0291</contrib-id>
                  <name>
                    <surname>Zoller</surname>
                    <given-names>Joseph A.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-7115-7174</contrib-id>
                  <name>
                    <surname>Shamshoian</surname>
                    <given-names>John</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2610-4644</contrib-id>
                  <name>
                    <surname>Sundin</surname>
                    <given-names>Phillip</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3915-9065</contrib-id>
                  <name>
                    <surname>Bufford</surname>
                    <given-names>Teresa</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-0662-9067</contrib-id>
                  <name>
                    <surname>Rimoin</surname>
                    <given-names>Anne W.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9818-479X</contrib-id>
                  <name>
                    <surname>Suchard</surname>
                    <given-names>Marc A.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Software</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8435-0416</contrib-id>
                  <name>
                    <surname>Ramirez</surname>
                    <given-names>Christina M.</given-names>
                  </name>
                  <role content-type="https://casrai.org/credit/">Conceptualization</role>
                  <role content-type="https://casrai.org/credit/">Data curation</role>
                  <role content-type="https://casrai.org/credit/">Funding acquisition</role>
                  <role content-type="https://casrai.org/credit/">Investigation</role>
                  <role content-type="https://casrai.org/credit/">Methodology</role>
                  <role content-type="https://casrai.org/credit/">Project administration</role>
                  <role content-type="https://casrai.org/credit/">Resources</role>
                  <role content-type="https://casrai.org/credit/">Supervision</role>
                  <role content-type="https://casrai.org/credit/">Validation</role>
                  <role content-type="https://casrai.org/credit/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Department of Biostatistics, Fielding School of Public Health, University of California, Los Angeles, California, United States of America</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Epidemiology, Fielding School of Public Health, University of California, Los Angeles, California, United States of America</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Departments of Computational Medicine and Human Genetics, David Geffen School of Medicine, University of California, Los Angeles, California, United States of America</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Pitzer</surname>
                    <given-names>Virginia E.</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Yale School of Public Health, UNITED STATES</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p>I have read the journal’s policy and the authors of this manuscript have the following competing interests: GLW, JAZ, PS, TB, and report personal fees from Private Health Management during the conduct of the study. CMR reports grants and personal fees from Private Health Management. MAS reports grants from US National Institutes of Health, grants from IQVIA, personal fees from Janssen Research and Development, and personal fees from Private Health Management during the conduct of the study. DX, LZ, JS, and AWR declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>gwatson@ucla.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="collection">
                <month>3</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="epub">
                <day>29</day>
                <month>3</month>
                <year>2021</year>
              </pub-date>
              <volume>17</volume>
              <issue>3</issue>
              <elocation-id>e1008837</elocation-id>
              <history>
                <date date-type="received">
                  <day>15</day>
                  <month>5</month>
                  <year>2020</year>
                </date>
                <date date-type="accepted">
                  <day>26</day>
                  <month>2</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>© 2021 Watson et al</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Watson et al</copyright-holder>
                <license>
                  <ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pcbi.1008837.pdf"/>
              <abstract>
                <p>Predictions of COVID-19 case growth and mortality are critical to the decisions of political leaders, businesses, and individuals grappling with the pandemic. This predictive task is challenging due to the novelty of the virus, limited data, and dynamic political and societal responses. We embed a Bayesian time series model and a random forest algorithm within an epidemiological compartmental model for empirically grounded COVID-19 predictions. The Bayesian case model fits a location-specific curve to the velocity (first derivative) of the log transformed cumulative case count, borrowing strength across geographic locations and incorporating prior information to obtain a posterior distribution for case trajectories. The compartmental model uses this distribution and predicts deaths using a random forest algorithm trained on COVID-19 data and population-level characteristics, yielding daily projections and interval estimates for cases and deaths in U.S. states. We evaluated the model by training it on progressively longer periods of the pandemic and computing its predictive accuracy over 21-day forecasts. The substantial variation in predicted trajectories and associated uncertainty between states is illustrated by comparing three unique locations: New York, Colorado, and West Virginia. The sophistication and accuracy of this COVID-19 model offer reliable predictions and uncertainty estimates for the current trajectory of the pandemic in the U.S. and provide a platform for future predictions as shifting political and societal responses alter its course.</p>
              </abstract>
              <abstract abstract-type="summary">
                <title>Author summary</title>
                <p>COVID-19 models can be roughly classified as mathematical models that simulate disease within a population, including epidemiological compartmental models, or statistical curve-fitting models that fit a function to observed data and extrapolate forward into the future. Bridging this divide, we combine the strengths of curve-fitting statistical models and the structure of epidemiological models, by embedding a Bayesian velocity model and a machine learning algorithm (random forest) into the framework of a compartmental model. Fusing these models together exploits the particular strengths of each to glean as much information as possible from the currently available data. We identify the velocity of log cumulative cases as an excellent target for modeling and extrapolating COVID-19 case trajectories. We empirically evaluate the predictive performance of the model and provide predicted trajectories with credible intervals for cumulative confirmed case count, active confirmed infections and COVID-19 deaths for each of the 50 U.S. states. Combining sophisticated data analytic methods with proven epidemiological models offers an empirically grounded strategy for making realistic predictions and quantifying their uncertainty. These predictions indicate substantial variation in the COVID-19 trajectories of U.S. states.</p>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution>Private Health Management</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7597-7359</contrib-id>
                    <name>
                      <surname>Watson</surname>
                      <given-names>Gregory L.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution>Private Health Management</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-6309-0291</contrib-id>
                    <name>
                      <surname>Zoller</surname>
                      <given-names>Joseph A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution>Private Health Management</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-2610-4644</contrib-id>
                    <name>
                      <surname>Sundin</surname>
                      <given-names>Phillip</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution>Private Health Management</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-3915-9065</contrib-id>
                    <name>
                      <surname>Bufford</surname>
                      <given-names>Teresa</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award005">
                  <funding-source>
                    <institution>Private Health Management</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9818-479X</contrib-id>
                    <name>
                      <surname>Suchard</surname>
                      <given-names>Marc A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award006">
                  <funding-source>
                    <institution>Private Health Management</institution>
                  </funding-source>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-8435-0416</contrib-id>
                    <name>
                      <surname>Ramirez</surname>
                      <given-names>Christina M.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group id="award007">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000002</institution-id>
                      <institution>National Institutes of Health</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>AI135995</award-id>
                  <principal-award-recipient>
                    <contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-9818-479X</contrib-id>
                    <name>
                      <surname>Suchard</surname>
                      <given-names>Marc A.</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <funding-statement>GLW, JAZ, PS, TB, MAS, and CMR received financial support from Private Health Management (<ext-link ext-link-type="uri" xlink:href="https://www.privatehealth.com/">https://www.privatehealth.com/</ext-link>) for this study. MAS was also supported through National Institutes of Health grant AI135995. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="5"/>
                <table-count count="0"/>
                <page-count count="20"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>PLOS Publication Stage</meta-name>
                  <meta-value>vor-update-to-uncorrected-proof</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>Publication Update</meta-name>
                  <meta-value>2021-04-08</meta-value>
                </custom-meta>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>The data underlying the results presented in the study are available from <ext-link ext-link-type="uri" xlink:href="https://github.com/COVID19Tracking/covid-tracking-data">https://github.com/COVID19Tracking/covid-tracking-data</ext-link>.</meta-value>
                </custom-meta>
                <custom-meta id="outbreaks">
                  <meta-name>Outbreaks</meta-name>
                  <meta-value>COVID-19</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>The data underlying the results presented in the study are available from <ext-link ext-link-type="uri" xlink:href="https://github.com/COVID19Tracking/covid-tracking-data">https://github.com/COVID19Tracking/covid-tracking-data</ext-link>.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec001">
              <title>Introduction</title>
              <p>Rapid spread of SARS-CoV-2 virus across the planet has precipitated a global pandemic, killing millions and infecting tens of millions. Governments around the world have undertaken unprecedented interventions aimed at curtailing the spread and lethality of the virus. These interventions have relied heavily on predictions of COVID-19 case growth and mortality.</p>
              <p>COVID-19 prediction models can be roughly classified as mathematical models that simulate disease within a population or statistical models that fit a function to observed data and extrapolate forward into the future. We will discuss the features of both types of models. Most COVID-19 models are compartmental models [<xref rid="pcbi.1008837.ref001" ref-type="bibr">1</xref>–<xref rid="pcbi.1008837.ref061" ref-type="bibr">61</xref>], a type of mathematical model used by epidemiologists to simulate infectious disease epidemics for over a century. Compartmental models divide a population into mutually exclusive compartments that denote disease status and supply a set of differential equations that define the flow of the population between compartments [<xref rid="pcbi.1008837.ref062" ref-type="bibr">62</xref>]. Traditionally they are named after their compartments with the SIR (susceptible-infectious-recovered) [<xref rid="pcbi.1008837.ref063" ref-type="bibr">63</xref>] and SEIR (susceptible-exposed-infectious-recovered) models as classic examples.</p>
              <p>In an infectious disease compartmental model, <italic>S</italic>(<italic>t</italic>) is the number of susceptible individuals at time <italic>t</italic>, and new infections are represented by the flow of individuals out of the S compartment. This is governed by the first derivative of <italic>S</italic>(<italic>t</italic>) with respect to time, <italic>dS</italic>(<italic>t</italic>)/<italic>dt</italic>. Classic SIR and SEIR models express this as proportional to the product of <italic>S</italic>(<italic>t</italic>), <italic>I</italic>(<italic>t</italic>), and a rate constant <italic>β</italic>,
<disp-formula id="pcbi.1008837.e001"><alternatives><graphic xlink:href="pcbi.1008837.e001.jpg" id="pcbi.1008837.e001g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M1"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>=</mml:mo><mml:mi>β</mml:mi><mml:mi>S</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mi>I</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(1)</label></disp-formula>
where <italic>I</italic>(<italic>t</italic>) is the number of infectious individuals at time <italic>t</italic>. The rate <italic>β</italic> is often interpreted as disease transmissibility and may be expressed as a function of the reproductive number <italic>R</italic><sub>0</sub>—the expected number of individuals infected by an infectious person—and contact rates between individuals. It may also be normalized in <xref ref-type="disp-formula" rid="pcbi.1008837.e001">Eq 1</xref> by division by the total population size.</p>
              <p>The simplest approach for simulating infections is to assume a value for <italic>β</italic> or its constituent parts from the literature or other prior information [<xref rid="pcbi.1008837.ref001" ref-type="bibr">1</xref>–<xref rid="pcbi.1008837.ref017" ref-type="bibr">17</xref>]. While this is convenient, the predictive accuracy can suffer. Another approach that has been used by other studies is to estimate <italic>β</italic> (or a related quantity) by fitting a statistical model or other optimization procedure to observed data [<xref rid="pcbi.1008837.ref018" ref-type="bibr">18</xref>–<xref rid="pcbi.1008837.ref039" ref-type="bibr">39</xref>]. This empirical approach can make these models more realistic, but they still may be limited in their ability to accurately model the COVID-19 pandemic. Disease transmission rates in COVID-19 have changed substantially over time depending upon the political and societal responses and possibly other factors [<xref rid="pcbi.1008837.ref054" ref-type="bibr">54</xref>]. As a result, modelers operating within this framework often resort to modeling transmission rate changes by applying an adjustment factor that modifies transmission rates upward or downward in a somewhat ad hoc manner.</p>
              <p>This has motivated modeling efforts that allow the disease transmission rate to vary over time, i.e., replacing <italic>β</italic> in <xref ref-type="disp-formula" rid="pcbi.1008837.e001">Eq 1</xref> with <italic>β</italic>(<italic>t</italic>) [<xref rid="pcbi.1008837.ref040" ref-type="bibr">40</xref>–<xref rid="pcbi.1008837.ref050" ref-type="bibr">50</xref>]. This is a promising approach, but to be useful for forecasting, estimates of <italic>β</italic>(<italic>t</italic>) must extrapolate beyond the observed data to describe transmission at unobserved times and not simply interpolate the observed data, which is straightforward with a flexible model. Several studies have paired machine learning algorithms with COVID-19 compartmental models to accommodate time-varying effects, which may be useful at least when inference on the inputs to <italic>β</italic> is not required. Yang et al. fit a long short-term memory neural network to data from the 2003 SARS outbreak adjusted by the output of their SEIR model [<xref rid="pcbi.1008837.ref045" ref-type="bibr">45</xref>]. Dandekar and Barbastathis augmented their compartmental models with a neural network that models time-varying transmission by estimating intervention efficiency from reported data as a function of time [<xref rid="pcbi.1008837.ref042" ref-type="bibr">42</xref>].</p>
              <p>Recovery, death, and other states (e.g., hospitalization) may be incorporated into the model as separate compartments. Solutions to the differential system provide values for each compartment at each time, allowing for easy joint modelling of disease states once their derivative is specified. This is an advantage of compartmental models over many other approaches, which may require separate models for each quantity.</p>
              <p>A number of agent-based COVID-19 models have been developed or adapted from influenza pandemic models to simulate the individuals of a population and their interactions [<xref rid="pcbi.1008837.ref064" ref-type="bibr">64</xref>–<xref rid="pcbi.1008837.ref068" ref-type="bibr">68</xref>]. This provides a mechanism for modelling interventions that target contacts between individuals and does not assume the population exists in homogeneous compartments as compartmental models generally do, but also requires a number of assumptions regarding the behavior and interactions within a population as well as the infectivity of COVID-19.</p>
              <p>Serial growth models for COVID-19 simulate an epidemic by expressing the number of new infections at a given time as a weighted sum of new infections on previous days usually scaled by the reproductive number, which may be time-varying [<xref rid="pcbi.1008837.ref069" ref-type="bibr">69</xref>–<xref rid="pcbi.1008837.ref072" ref-type="bibr">72</xref>]. The weights are sampled from a probability distribution defining the amount of time between an individual being infected and infecting another person. Deaths or other outcomes may be modeled as a second step.</p>
              <p>Statistical models often eschew deterministic population dynamics and fit the observed data as a function of time and possibly other covariates in a regression (or equivalent) framework. Log-linear [<xref rid="pcbi.1008837.ref073" ref-type="bibr">73</xref>], generalized Richards [<xref rid="pcbi.1008837.ref074" ref-type="bibr">74</xref>], ARIMA [<xref rid="pcbi.1008837.ref075" ref-type="bibr">75</xref>, <xref rid="pcbi.1008837.ref076" ref-type="bibr">76</xref>], exponential [<xref rid="pcbi.1008837.ref077" ref-type="bibr">77</xref>], Gaussian CDF [<xref rid="pcbi.1008837.ref078" ref-type="bibr">78</xref>], and logistic [<xref rid="pcbi.1008837.ref079" ref-type="bibr">79</xref>–<xref rid="pcbi.1008837.ref081" ref-type="bibr">81</xref>] models, which all accommodate the generally sigmoidal shape of the cumulative infection count that is often observed in epidemics, as well as various other models [<xref rid="pcbi.1008837.ref082" ref-type="bibr">82</xref>–<xref rid="pcbi.1008837.ref085" ref-type="bibr">85</xref>] including machine learning algorithms [<xref rid="pcbi.1008837.ref086" ref-type="bibr">86</xref>–<xref rid="pcbi.1008837.ref088" ref-type="bibr">88</xref>] have been proposed for COVID-19. Murray et al. and Woody et al. take similar approaches for modeling COVID-19 deaths using the error function (ERF) [<xref rid="pcbi.1008837.ref089" ref-type="bibr">89</xref>, <xref rid="pcbi.1008837.ref090" ref-type="bibr">90</xref>]. Count models (e.g., negative binomial) for the number of daily deaths is an alternative for modeling COVID-19 deaths [<xref rid="pcbi.1008837.ref091" ref-type="bibr">91</xref>]. Modeling deaths is appealing, because they have been more reliably reported than infections. However, because deaths lag infections by some amount of time, it may not enable projections to incorporate the latest information on disease spread.</p>
              <p>Within the framework of a statistical (or other regression-like) model, it is easier to fit observed data, assuming an appropriate functional form is selected, but it may be challenging to accurately project the future trajectory of an epidemic. Time-varying covariates like mobile phone tracking data [<xref rid="pcbi.1008837.ref090" ref-type="bibr">90</xref>], Google trends [<xref rid="pcbi.1008837.ref088" ref-type="bibr">88</xref>, <xref rid="pcbi.1008837.ref092" ref-type="bibr">92</xref>], and social media [<xref rid="pcbi.1008837.ref093" ref-type="bibr">93</xref>] are easily incorporated into such a model and may be quite predictive of the observed data. These data are not a panacea, however, as forecasting requires knowledge of their values at future times, which are as yet unobserved. The forecasting accuracy of a model incorporating these covariates can depend heavily upon the accuracy of the assumptions made regarding their future values. Because of the challenges in jointly modeling multiple, non-Gaussian outcomes in a statistical model, regression approaches generally only model one outcome (e.g., infections or deaths) and additional steps must be taken to predict other quantities.</p>
              <p>Here we project COVID-19 cases and deaths using a combination of Bayesian and machine learning data analytic methods to learn transition functions for a compartmental model. We introduce the velocity of log cumulative cases as a useful target for predicting case growth, and propose a Bayesian time series model that provides location-specific trajectories that extrapolate well within a full probability model, including uncertainty quantification. We use a random forest algorithm for the death transition function that learns the relationship between COVID-19 cases and population characteristics to predict deaths. We fuse the case and death models together by embedding them within a compartmental model that also provides projections for active cases and confirmed recoveries. The next section opens by introducing the data and presenting an overview of the model. Then it lays out in detail the Bayesian velocity model, the random forest death model, and the SIRD compartmental model. Lastly the paper closes with results and a discussion.</p>
            </sec>
            <sec sec-type="materials|methods" id="sec002">
              <title>Materials and methods</title>
              <sec id="sec003">
                <title>Data</title>
                <p>Daily COVID-19 confirmed cases and deaths for each state were obtained from the COVID Tracking Project, which combines information from state health departments and other sources [<xref rid="pcbi.1008837.ref094" ref-type="bibr">94</xref>]. The relationship between confirmed COVID-19 cases and the true number of infections is complicated, especially for the U.S., due to the substantial proportion of infections which are asymptomatic [<xref rid="pcbi.1008837.ref095" ref-type="bibr">95</xref>] and severely limited testing early in the pandemic [<xref rid="pcbi.1008837.ref096" ref-type="bibr">96</xref>]. Not only are confirmed cases a subset of COVID-19 infections, but the proportion of confirmed infections has differed across states and over the course of the pandemic as the prevalence and severity of cases as well as the availability of testing have changed. These difficulties pose challenges for basing a COVID-19 model on confirmed cases. As noted above, some modelers have focused on modeling deaths, since the death data is more reliable, and estimate infections in the preceding weeks as a second step [<xref rid="pcbi.1008837.ref089" ref-type="bibr">89</xref>, <xref rid="pcbi.1008837.ref091" ref-type="bibr">91</xref>].</p>
                <p>We model COVID-19 confirmed cases despite these challenges, because they are the best source of information on the current state of infections. The death data may be more accurate, but since deaths lag infections by several weeks they do not provide up-to-date insight into infections. While confirmed cases are a poor estimate of the total number of infections, they are still indicative of the prevalence and severity of disease spread. The shifting meaning of a confirmed case is indeed suboptimal, which motivates the use of a death model with a flexible mean structure that can learn the changing relationship between cases and deaths over the course of the pandemic.</p>
              </sec>
              <sec id="sec004">
                <title>Model overview</title>
                <p>There are three primary components to our model: (1) the velocity model for predicting new confirmed cases, (2) the death model for predicting how many cases end in death, and (3) a four compartment epidemiological model that fuses these together to provide joint predictions of cases, deaths and recoveries. The case model and the death model become transition functions within the compartmental model. There are several advantages to this combined approach. First, the SIRD model provides a joint model for cases, deaths and recoveries, allowing simultaneous forecasting of these. This is an advantage over univariate models, including statistical regression models and machine learning prediction tools, which can only forecast one outcome. Second, the combined approach incorporates information on projected case growth into death predictions in a very flexible manner, which would not be available if the models were separate or if a less flexible death model were used. Third, the velocity model for projecting case growth both fits the observed data and extrapolates well, which is a challenge for curve-fitting approaches. Fourth, we incorporate uncertainty of model fit into the compartmental forecasts, by running it many times—once for each posterior sample from the Bayesian case model. R code for fitting the models, producing forecasting and generating figures is available at <ext-link ext-link-type="uri" xlink:href="https://github.com/gregorywatson/covidStateSird">https://github.com/gregorywatson/covidStateSird</ext-link>.</p>
              </sec>
              <sec id="sec005">
                <title>Bayesian velocity model for forecasting cases</title>
                <p>We forecast new COVID-19 cases by modeling the velocity of the log cumulative cases. Forecasting COVID-19 cases in this velocity domain is appealing, because it reveals seemingly subtle shifts in case trajectory that are not obvious when considering raw case counts. Let <italic>u</italic><sub><italic>i</italic></sub>(<italic>t</italic>) denote the cumulative case count for location <italic>i</italic> at time <italic>t</italic>. The velocity (the first derivative with respect to time) of the log transformed cumulative cases is the instantaneous rate of new cases to cumulative cases at a given time,
<disp-formula id="pcbi.1008837.e002"><alternatives><graphic xlink:href="pcbi.1008837.e002.jpg" id="pcbi.1008837.e002g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M2"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mspace width="2pt"/><mml:mtext>log</mml:mtext><mml:mspace width="2pt"/><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:mo>·</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>
which is related to the reproductive number, but is readily estimated from the data. Calculating the reproductive number at a particular time, on the other hand, requires knowing the number of active infections. There is currently no reliable data on this, as most infections resolve on their own outside of a clinical or otherwise supervised setting in which their transition from active case to recovered might be recorded.</p>
                <p>A crude estimate of the derivative can be obtained using first differences, but smoothing allows for more precise estimates, as calculating the derivative requires some notion of function smoothness [<xref rid="pcbi.1008837.ref097" ref-type="bibr">97</xref>]. We estimate the velocity by fitting a cubic spline to the observed log cumulative case count and then evaluating its derivative at the observed time points. Since there is relatively little noise in the cumulative counts, we assume any uncertainty introduced by this procedure is negligible.</p>
                <p><xref ref-type="fig" rid="pcbi.1008837.g001">Fig 1</xref> depicts cumulative cases, log cumulative cases, and the velocity of log cumulative cases for 3 example U.S. states, New York (NY), Colorado (CO), and West Virginia (WV). The horizontal axis enumerates days since 100 or more confirmed cases were reported in that state, a milestone that proxies for the establishment of community transmission. Community transmission or its proxy is a sensible time point for data alignment, because there is substantial variation observed in the length of time between the detection of the first cases in a location and the acceleration of cases accompanying community transmission. This variation likely reflects both the possibility of containing a small number of initial cases and the increased uncertainty accompanying small samples.</p>
                <fig id="pcbi.1008837.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pcbi.1008837.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Log cumulative cases and its velocity.</title>
                    <p>The cumulative case count (a), the log cumulative confirmed case count (b) and its velocity (c), i.e., first derivative with respect to time, for three example states, New York (NY), Colorado (CO), and West Virginia (WV) since 100 or more confirmed cases were reported.</p>
                  </caption>
                  <graphic xlink:href="pcbi.1008837.g001"/>
                </fig>
                <p>The velocity of a cumulative function cannot be negative, since cumulative functions are monotonically increasing. Consequently, we employed a log link to map velocity to the entire real line and modeled it with a Bayesian autoregressive (AR-1) time series model. We estimated location-specific parameters, borrowing strength across locations for more precise estimates while accommodating individual variation. Borrowing strength can be particularly helpful for estimating the trajectory of locations with smaller populations or less advanced outbreaks.</p>
                <p>Let <italic>y</italic><sub><italic>i</italic></sub>(<italic>t</italic>) denote the derivative of log cumulative cases for location <italic>i</italic> at time <italic>t</italic>, i.e., <italic>y</italic><sub><italic>i</italic></sub>(<italic>t</italic>) = <italic>d</italic> log <italic>u</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic>. Log-transformed velocity is modeled as
<disp-formula id="pcbi.1008837.e003"><alternatives><graphic xlink:href="pcbi.1008837.e003.jpg" id="pcbi.1008837.e003g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M3"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>log</mml:mtext><mml:mspace width="2pt"/><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mspace width="2pt"/><mml:mtext>log</mml:mtext><mml:mspace width="2pt"/><mml:msub><mml:mi>y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>+</mml:mo><mml:msub><mml:mi>ϵ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(2)</label></disp-formula>
where <italic>y</italic><sub><italic>i</italic></sub>(<italic>t</italic>) is the velocity at time <italic>t</italic> ∈ {2, …, <italic>n</italic><sub><italic>i</italic></sub>}, <italic>μ</italic><sub><italic>i</italic></sub> is a location-specific constant, <italic>ϕ</italic><sub><italic>i</italic></sub> a location-specific coefficient encoding the dependence on the previous time point, and <italic>ϵ</italic><sub><italic>i</italic></sub>(<italic>t</italic>) is independently distributed Gaussian noise with mean 0 and precision (inverse variance) <italic>τ</italic><sub><italic>i</italic></sub>, i.e.,
<disp-formula id="pcbi.1008837.e004"><alternatives><graphic xlink:href="pcbi.1008837.e004.jpg" id="pcbi.1008837.e004g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M4"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi mathvariant="bold-italic">ϵ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi>τ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∼</mml:mo><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mn mathvariant="bold">0</mml:mn><mml:mo>,</mml:mo><mml:msubsup><mml:mi>τ</mml:mi><mml:mi>i</mml:mi><mml:mrow><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msubsup><mml:msub><mml:mi>I</mml:mi><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(3)</label></disp-formula>
where <inline-formula id="pcbi.1008837.e005"><alternatives><graphic xlink:href="pcbi.1008837.e005.jpg" id="pcbi.1008837.e005g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M5"><mml:msub><mml:mi>N</mml:mi><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub></mml:math></alternatives></inline-formula> is an <italic>n</italic><sub><italic>i</italic></sub> dimensional Gaussian distribution, its mean <bold>0</bold> is a vector of zeros, and <inline-formula id="pcbi.1008837.e006"><alternatives><graphic xlink:href="pcbi.1008837.e006.jpg" id="pcbi.1008837.e006g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M6"><mml:msub><mml:mi>I</mml:mi><mml:msub><mml:mi>n</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msub></mml:math></alternatives></inline-formula> is the identity matrix. The precision parameters were assigned a gamma prior distribution with mean <italic>μ</italic><sub><italic>τ</italic></sub> and variance <inline-formula id="pcbi.1008837.e007"><alternatives><graphic xlink:href="pcbi.1008837.e007.jpg" id="pcbi.1008837.e007g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M7"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>τ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>,
<disp-formula id="pcbi.1008837.e008"><alternatives><graphic xlink:href="pcbi.1008837.e008.jpg" id="pcbi.1008837.e008g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M8"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>τ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>τ</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>τ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>∼</mml:mo><mml:mi>G</mml:mi><mml:mi>a</mml:mi><mml:mi>m</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>μ</mml:mi><mml:mi>τ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>/</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>τ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>τ</mml:mi></mml:msub><mml:mo>/</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>τ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(4)</label></disp-formula>
with <italic>μ</italic><sub><italic>τ</italic></sub> itself having a gamma hyperprior. The location-specific constant <italic>μ</italic><sub><italic>i</italic></sub> is assumed to be nonpositive, since we know that the velocity must eventually go to zero. Consequently, it was assigned a negative lognormal prior distribution, i.e.,
<disp-formula id="pcbi.1008837.e009"><alternatives><graphic xlink:href="pcbi.1008837.e009.jpg" id="pcbi.1008837.e009g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M9"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mo>−</mml:mo><mml:mtext>log</mml:mtext><mml:mspace width="2pt"/><mml:msub><mml:mi>μ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>μ</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>μ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>∼</mml:mo><mml:mi>N</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>μ</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>μ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(5)</label></disp-formula>
with <italic>μ</italic><sub><italic>μ</italic></sub> having a Gaussian prior. The autoregressive coefficients <italic>ϕ</italic><sub><italic>i</italic></sub> were given a beta prior with mean <italic>μ</italic><sub><italic>ϕ</italic></sub> and variance <inline-formula id="pcbi.1008837.e010"><alternatives><graphic xlink:href="pcbi.1008837.e010.jpg" id="pcbi.1008837.e010g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M10"><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:math></alternatives></inline-formula>,
<disp-formula id="pcbi.1008837.e011"><alternatives><graphic xlink:href="pcbi.1008837.e011.jpg" id="pcbi.1008837.e011g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M11"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi></mml:msub><mml:mo>,</mml:mo><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>∼</mml:mo><mml:mi>B</mml:mi><mml:mi>e</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mo>(</mml:mo><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi></mml:msub></mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi></mml:msub></mml:mfrac><mml:mo>]</mml:mo><mml:msubsup><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>,</mml:mo><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mn>1</mml:mn><mml:mo>−</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi></mml:msub></mml:mrow><mml:msubsup><mml:mi>σ</mml:mi><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msubsup></mml:mfrac><mml:mo>−</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi></mml:msub></mml:mfrac><mml:mo>]</mml:mo><mml:msubsup><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi><mml:mn>2</mml:mn></mml:msubsup><mml:mo>[</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:msub><mml:mi>μ</mml:mi><mml:mi>ϕ</mml:mi></mml:msub></mml:mfrac><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>]</mml:mo><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(6)</label></disp-formula>
with <italic>μ</italic><sub><italic>ϕ</italic></sub> having a uniform hyperprior between 0 and 1. The prior mean and variance values used for the predictions presented here are listed in <xref ref-type="supplementary-material" rid="pcbi.1008837.s003">S1 Table</xref>.</p>
                <p>Posterior inference was conducted via Markov chain Monte Carlo (MCMC) simulation using JAGS 4.3.0 and the <monospace>R2jags</monospace> [<xref rid="pcbi.1008837.ref098" ref-type="bibr">98</xref>] package of R. Three chains of 200,000 iterations each were run after a burn in of 10,000 iterations and thinned to save every 1,500th sample.</p>
                <p>The posterior samples of this velocity model provide forecasts for log <italic>d</italic> log <italic>u</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic>, which we convert into a transition function for our compartmental model. Transition out of the susceptible compartment is governed by an expression for <italic>dS</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic>. The number of individuals who are no longer susceptible is the number of cumulative cases, i.e., <italic>u</italic><sub><italic>i</italic></sub>(<italic>t</italic>) = <italic>N</italic><sub><italic>i</italic></sub> − <italic>S</italic><sub><italic>i</italic></sub>(<italic>t</italic>), where <italic>N</italic><sub><italic>i</italic></sub> is the total population of location <italic>i</italic>. Since <italic>dS</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic> = −<italic>du</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic>, we can convert our posterior distribution for <italic>d</italic> log <italic>u</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic> into a transition function. The autoregressive model for log <italic>d</italic> log <italic>u</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic> in <xref ref-type="disp-formula" rid="pcbi.1008837.e003">Eq 2</xref> can be converted into an expression for <italic>du</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic> for use in the compartmental model,
<disp-formula id="pcbi.1008837.e012"><alternatives><graphic xlink:href="pcbi.1008837.e012.jpg" id="pcbi.1008837.e012g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M12"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:msup><mml:mrow><mml:mo>[</mml:mo><mml:mfrac><mml:mrow><mml:mfrac><mml:mi>d</mml:mi><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>]</mml:mo></mml:mrow><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:msup><mml:mtext>exp</mml:mtext><mml:mo>[</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mn>2</mml:mn><mml:msub><mml:mi>τ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mrow></mml:mfrac><mml:mo>]</mml:mo><mml:mfrac><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi>t</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>)</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula></p>
                <p>The details of this derivation are in <xref ref-type="supplementary-material" rid="pcbi.1008837.s001">S1 Appendix</xref>.</p>
                <p>Noting that <italic>N</italic><sub><italic>i</italic></sub> − <italic>S</italic><sub><italic>i</italic></sub>(<italic>t</italic>) gives the cumulative number of cases at time <italic>t</italic> in the compartmental model described above, we set
<disp-formula id="pcbi.1008837.e013"><alternatives><graphic xlink:href="pcbi.1008837.e013.jpg" id="pcbi.1008837.e013g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M13"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>d</mml:mi><mml:msub><mml:mi>S</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mspace width="3.33333pt"/><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>d</mml:mi><mml:msub><mml:mi>u</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>/</mml:mo><mml:mi>d</mml:mi><mml:mi>t</mml:mi><mml:mspace width="3.33333pt"/><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:msub><mml:mi>ξ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>
The posterior mean or median of −<italic>du</italic><sub><italic>i</italic></sub>(<italic>t</italic>)/<italic>dt</italic> could be used to estimate <italic>ξ</italic>(<italic>t</italic>), but simply plugging in this single function into the SIRD model would ignore the uncertainty of this estimate. To incorporate this uncertainty explicitly into the SIRD model, we run the model separately for each posterior sample, giving a distribution of rate transition functions, <italic>ξ</italic><sub><italic>i</italic></sub>(<italic>t</italic>)<sup>(1)</sup>, …, <italic>ξ</italic><sub><italic>i</italic></sub>(<italic>t</italic>)<sup>(<italic>m</italic>)</sup>. Accounting for uncertainty is important for COVID-19 forecasts, because without interval estimates quantifying uncertainty decision makers may place undue confidence in their accuracy.</p>
              </sec>
              <sec id="sec006">
                <title>Death model</title>
                <p>We constructed a random forest to predict deaths in each state on each day, using demographic characteristics of the state population and the number of COVID-19 cases and deaths reported on each of the preceding 21 days. This model would be useless for predicting deaths in most context, because lagged cases and deaths are unknown at future dates. However, within the compartmental model, it uses the case forecast provided by the velocity model in the previous section.</p>
                <p>Random forest is a widely used heuristic machine learning prediction algorithm known to perform well at a variety of predictive tasks [<xref rid="pcbi.1008837.ref099" ref-type="bibr">99</xref>] by combining a large number of regression or classification trees into an ensemble [<xref rid="pcbi.1008837.ref100" ref-type="bibr">100</xref>]. We selected random forest for the death model over alternatives such as time series models, for 4 reasons: (1) in this context, we care only about predicting deaths given recent cases, deaths and other covariates rendering the interpretive and inferential advantages of time series models moot; (2) the flexible mean structure of random forest accommodates nonlinear effects, interactions and provides implicit variable selection, all of which are much more challenging in a time series context; (3) each death model prediction is only one day into the future, not an entire time series; and (4) the relationship between cases and deaths appears to have shifted in the U.S. throughout the course of the pandemic so far (for reasons that are not entirely clear—increased testing, better treatment protocols, a younger infected population, and viral attenuation may be contributing factors), suggesting that a nonstationary time series model would be needed, making the process of fitting such a model even more challenging.</p>
                <p>Let <italic>d</italic><sub><italic>ij</italic></sub> denote the number of dead reported in location <italic>i</italic> on day <italic>j</italic>, where days are indexed for each location from the first day on which 100 or more cumulative confirmed cases were reported in that location. Let <bold>w</bold><sub><italic>ij</italic></sub> = (<italic>w</italic><sub><italic>ij</italic>1</sub>, …, <italic>w</italic><sub><italic>ijp</italic></sub>)′ denote the vector of <italic>p</italic> covariates for location <italic>i</italic> on day <italic>j</italic>. The conditional expectation of <italic>d</italic><sub><italic>ij</italic></sub> given covariates <bold>w</bold><sub><italic>ij</italic></sub> is modeled as a random forest, i.e., as an ensemble of bootstrapped regression trees,
<disp-formula id="pcbi.1008837.e014"><alternatives><graphic xlink:href="pcbi.1008837.e014.jpg" id="pcbi.1008837.e014g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M14"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mtext>E</mml:mtext><mml:msub><mml:mi>d</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>∣</mml:mo><mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mn>1</mml:mn><mml:mi>B</mml:mi></mml:mfrac><mml:munderover><mml:mo>∑</mml:mo><mml:mrow><mml:mi>b</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>B</mml:mi></mml:munderover><mml:msub><mml:mi>T</mml:mi><mml:mi>b</mml:mi></mml:msub><mml:mrow><mml:mo>(</mml:mo><mml:msub><mml:mi mathvariant="bold">w</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mi>j</mml:mi></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi mathvariant="bold-italic">φ</mml:mi><mml:mi>b</mml:mi></mml:msub><mml:mo>)</mml:mo></mml:mrow><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(7)</label></disp-formula>
where <italic>b</italic> = 1, …, <italic>B</italic> indexes bootstrap samples of the training data, and <italic>T</italic><sub><italic>b</italic></sub>(<bold>w</bold><sub><italic>ij</italic></sub>, <bold><italic>φ</italic></bold><sub><italic>b</italic></sub>) is a regression tree trained on the <italic>b</italic>-th bootstrap sample that relates covariate vector <bold>w</bold><sub><italic>ij</italic></sub> to parameters <bold><italic>φ</italic></bold><sub><italic>b</italic></sub>. The model was fit using the <monospace>randomForest</monospace> package [<xref rid="pcbi.1008837.ref101" ref-type="bibr">101</xref>] of R using the default parameter values for the number of trees (500) and the number of covariates considered for each recursive split of the covariate space (floor(<italic>p</italic>/3)). To quantify the uncertainty associated with random forest predictions, we follow the procedure devised by Zhang et al. to produce 95% prediction intervals from the out-of-bag errors [<xref rid="pcbi.1008837.ref102" ref-type="bibr">102</xref>, <xref rid="pcbi.1008837.ref103" ref-type="bibr">103</xref>]. This results in a prediction interval for each run of the compartmental model. We take the fifth quantile of the lower bounds and the 95th quantile of the upper bounds to produce an overall prediction interval.</p>
                <p><xref ref-type="fig" rid="pcbi.1008837.g002">Fig 2</xref> lists the covariates included in the model and their importance scores. Age, sex and comorbidity have been consistently reported in the literature as important risk factors for COVID-19 mortality. Even in the U.S. where testing has been limited, we expected that COVID-19 deaths on a particular day would be highly related to the number of cases and deaths reported on preceding days. Consequently the number of newly reported COVID-19 cases and deaths in location <italic>i</italic> on days <italic>t</italic> − 1, …, <italic>t</italic> − 21 were included as covariates for predicting deaths on day <italic>t</italic>.</p>
                <fig id="pcbi.1008837.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pcbi.1008837.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Death model covariate importance.</title>
                    <p>Covariate importance scores on the log scale for the random forest death model as the mean decrease in MSE associated with permutation of the variable’s values.</p>
                  </caption>
                  <graphic xlink:href="pcbi.1008837.g002"/>
                </fig>
                <p>Covariate importance scores were computed using permutation variable importance. Briefly, the permutation importance of a covariate is the decrease in predictive accuracy (in terms of mean squared error (MSE)) comparing the original model and a model in which that variable is randomly permuted to obscure any signal it might have with the outcome variable. If a covariate is important in terms of prediction, obscuring its signal should result in a decrease in predictive accuracy. Not surprisingly, lagged deaths are highly important and to a lesser extent cases and time. Interestingly there appears to be a weekly periodicity to the lagged importance as there are peaks at <italic>t</italic> − 1, <italic>t</italic> − 8 and <italic>t</italic> − 15 especially for deaths. This is likely due to the effect of the workweek on data reporting. Additional lagged data beyond 21 days did not improve predictive performance, and so were not included in the model.</p>
                <p>Fitting the model to data collected through December 31, 2020, resulted in an out-of-bag <italic>R</italic><sup>2</sup> of 0.96. This is an overly optimistic estimate of prediction error, due to the within-location and temporal dependence of the data [<xref rid="pcbi.1008837.ref104" ref-type="bibr">104</xref>], but more significantly due to the lagged data being very informative covariates. Lagged deaths and cases were far more important than the demographic characteristics, which is not surprising considering the very strong relationship between testing positive for COVID-19 and dying of COVID-19, especially in the early days of the pandemic in the U.S., when testing was quite limited. Within the compartmental model, the lagged data are estimated, not observed, and so introduce uncertainty into the forecast. The random forest predictions were capped at a percentage of the new cases to avoid unrealistically high death predictions, which can occur when there are relatively few new cases. This upper bound was set to be equivalent to a 15% case fatality rate for the first 30 days of the epidemic and reduced to 7% subsequently, with the higher initial death rate motivated by the relative severity of early confirmed cases due to limited testing.</p>
              </sec>
              <sec id="sec007">
                <title>The SIRD compartmental model</title>
                <p>We combine the case and death models to forecast the spread and progression of COVID-19 through the populations of U.S. states using a SIRD compartmental model named after the four compartments into which it partitions the population: <italic>S</italic> for susceptible, <italic>I</italic> for infectious, <italic>R</italic> for recovered, and <italic>D</italic> for dead. The compartmental model allows for the joint forecasting of these quantities, a distinct advantage over many approaches including so-called black box prediction tools that generally only model a single outcome. The posterior samples from the velocity model provide a mechanism for uncertainty quantification that can be propagated through the compartmental model. The compartmental model also allows the case forecast to be used as covariates in the death model, which otherwise would not provide predictions beyond one day past the observed data.</p>
                <p>The number of population members in each compartment is a function of time, <italic>t</italic>, and these functions are linked by a system of ordinary differential equations (ODEs) that govern the flow of the population through the different disease states:
<disp-formula id="pcbi.1008837.e015"><alternatives><graphic xlink:href="pcbi.1008837.e015.jpg" id="pcbi.1008837.e015g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M15"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>S</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mo>−</mml:mo><mml:mi>ξ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mi>ξ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:mi>ρ</mml:mi><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>R</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mi>ρ</mml:mi><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>−</mml:mo><mml:mi>θ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd columnalign="right"><mml:mfrac><mml:mrow><mml:mi>d</mml:mi><mml:mi>D</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>d</mml:mi><mml:mi>t</mml:mi></mml:mrow></mml:mfrac></mml:mtd><mml:mtd columnalign="left"><mml:mrow><mml:mo>=</mml:mo><mml:mi>θ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(8)</label></disp-formula>
<xref ref-type="fig" rid="pcbi.1008837.g003">Fig 3</xref> graphically depicts the SIRD model with arrows between compartments indicating possible transitions between compartments. Only deaths due to COVID-19 are permitted within this framework under the assumption that ignoring other causes of death, as well as the influx of new susceptible persons through birth or immigration, will not substantially alter inference in the short term.</p>
                <fig id="pcbi.1008837.g003" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pcbi.1008837.g003</object-id>
                  <label>Fig 3</label>
                  <caption>
                    <title>The SIRD model.</title>
                    <p>Each of the four compartments quantifies the number of population members with that disease status: S for susceptible, I for infectious, R for recovered and D for dead. The arrows indicate possible transitions between disease states.</p>
                  </caption>
                  <graphic xlink:href="pcbi.1008837.g003"/>
                </fig>
                <p>The transition rates between compartments are determined by the functional forms and parameter values in <xref ref-type="disp-formula" rid="pcbi.1008837.e015">Eq 8</xref>. Given these and initial conditions for the system, <italic>S</italic>(<italic>t</italic><sub>0</sub>), <italic>I</italic>(<italic>t</italic><sub>0</sub>), <italic>R</italic>(<italic>t</italic><sub>0</sub>), and <italic>D</italic>(<italic>t</italic><sub>0</sub>), the system of ODEs in <xref ref-type="disp-formula" rid="pcbi.1008837.e015">Eq 8</xref> is deterministic, but in general does not accommodate analytical solutions. Consequently, we compute numerical solutions using the <monospace>lsoda</monospace> solver in the <monospace>deSolve</monospace> package [<xref rid="pcbi.1008837.ref105" ref-type="bibr">105</xref>] of R [<xref rid="pcbi.1008837.ref106" ref-type="bibr">106</xref>].</p>
                <p>Due to the novelty of the SARS-CoV-2 virus and a desire to empirically ground the compartmental model, we fit transition functions that can vary in time and incorporate covariates and other information. The transition between S and I is determined by <italic>ξ</italic>(<italic>t</italic>), which describes the number of individuals becoming confirmed COVID-19 cases. This differs from traditional compartmental models. The standard expression for <italic>dI</italic>(<italic>t</italic>)/<italic>dt</italic> is <italic>βS</italic>(<italic>t</italic>)<italic>I</italic>(<italic>t</italic>) (sometimes divided by the population size <italic>N</italic>) as described in the introduction. We found the traditional functional form for <italic>dI</italic>(<italic>t</italic>)/<italic>dt</italic> fit the observed data very poorly, which motivated its replacement by <italic>ξ</italic>(<italic>t</italic>), a time-varying function derived from the velocity model described above. Importantly, <italic>ξ</italic>(<italic>t</italic>) does not depend on <italic>I</italic>(<italic>t</italic>), which is a departure from traditional compartmental models and is similar to the approach of so-called curve-fitting models. This hybrid approach was motivated by a desire to retain the benefits of compartmental models while exploiting the substantially better empirical accuracy of curve-fitting models for the changing number of cases.</p>
                <p>Traditional SIR compartmental models use a rate parameter, which we call <italic>ρ</italic>, that is the inverse of the time an individual is expected to be infectious to model the movement of individuals out of the infectious compartment. We follow this approach, but split the R compartment into R and D, because we have reliable data on COVID-19 deaths, but not on recoveries. (Some states have reported recoveries, but in most instances this is limited to hospitalized patients who have recovered.) Like a traditional SIR model, we let <italic>ρI</italic>(<italic>t</italic>) denote individuals exiting the infectious compartment, which corresponds to the −<italic>ρI</italic>(<italic>t</italic>) term in <italic>dI</italic>(<italic>t</italic>)/<italic>dt</italic>. Since individuals do not enter compartment I until they test positive, in our model <italic>ρ</italic><sup>−1</sup> is the length of time we expect an individual to remain infectious after testing positive. Using onset of symptoms as a proxy for testing positive, we sample <italic>ρ</italic><sup>−1</sup> independently for each run from a Gaussian distribution with mean 10 and standard deviation 1, based on Wölfel et al. estimating the probability of isolating virus dropping below 5% at 9.78 days after symptom onset [<xref rid="pcbi.1008837.ref107" ref-type="bibr">107</xref>]. The death model, <italic>θ</italic>(<italic>t</italic>), indicates how many of these die, i.e., <italic>dD</italic>(<italic>t</italic>)/<italic>dt</italic> = <italic>θ</italic>(<italic>t</italic>), with the remainder of the <italic>ρI</italic>(<italic>t</italic>) recovering, i.e., <italic>dR</italic>(<italic>t</italic>)/<italic>dt</italic> = <italic>ρI</italic>(<italic>t</italic>) − <italic>θ</italic>(<italic>t</italic>).</p>
                <p>In addition to the SIRD forecasts of infections, deaths and recoveries, we estimate the effective reproductive number, <italic>R</italic><sub><italic>t</italic></sub>. This is the average number of new cases that each case will generate. We estimate this as
<disp-formula id="pcbi.1008837.e016"><alternatives><graphic xlink:href="pcbi.1008837.e016.jpg" id="pcbi.1008837.e016g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M16"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>R</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mi>ρ</mml:mi><mml:mfrac><mml:mrow><mml:mi>ξ</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow><mml:mrow><mml:mi>I</mml:mi><mml:mo>(</mml:mo><mml:mi>t</mml:mi><mml:mo>)</mml:mo></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives></disp-formula>
and report its ten-day moving average. We also include state-specific, time-varying estimates of case doubling time, death doubling time and the proportion of cases resolving in subject death.</p>
                <p>A unique initial condition was constructed for each run of the compartmental model by stepping the model through each day of the observed data and fixing the number of cases and deaths to the observed values while using the recovery transition function to distribute cases between compartments I and R. This combines the observed case data while attempting to account for the uncertainty in the number of individuals in I and R using the randomness in the recovery function. Using the observed case data and incorporating uncertainty reduces the sensitivity of the model to the choice of initial conditions. This approach ignores any measurement error in the case and death data, which is a substantial limitation considering the status of COVID-19 case data in the US, as discussed above.</p>
              </sec>
              <sec id="sec008">
                <title>Predictive accuracy</title>
                <p>We assessed the predictive accuracy by training the model on case and death data collected through the end of August, September, October and November 2020, and forecasting the subsequent 21 days. We quantified prediction error for each state on each day using the mean absolute scaled error (MASE) of the posterior median number of new cases and deaths. MASE is computed by dividing the mean absolute prediction error by the in-sample mean absolute error (MAE) of a naive random walk forecast,
<disp-formula id="pcbi.1008837.e017"><alternatives><graphic xlink:href="pcbi.1008837.e017.jpg" id="pcbi.1008837.e017g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M17"><mml:mtable displaystyle="true"><mml:mtr><mml:mtd columnalign="right"><mml:mrow><mml:mi>M</mml:mi><mml:mi>A</mml:mi><mml:mi>S</mml:mi><mml:mi>E</mml:mi><mml:mrow><mml:mo>(</mml:mo><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>,</mml:mo><mml:mover accent="true"><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mo>)</mml:mo></mml:mrow><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mi>m</mml:mi></mml:mfrac><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>m</mml:mi></mml:msubsup><mml:mrow><mml:mo>|</mml:mo><mml:msubsup><mml:mi>Y</mml:mi><mml:mi>j</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>−</mml:mo><mml:msub><mml:mover accent="true"><mml:mi>Y</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>j</mml:mi></mml:msub><mml:mo>|</mml:mo></mml:mrow></mml:mrow><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>n</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfrac><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>2</mml:mn></mml:mrow><mml:mi>n</mml:mi></mml:msubsup><mml:mrow><mml:mo>|</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>−</mml:mo><mml:msub><mml:mi>Y</mml:mi><mml:mrow><mml:mi>i</mml:mi><mml:mo>−</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>|</mml:mo></mml:mrow></mml:mrow></mml:mfrac><mml:mo>,</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:math></alternatives><label>(9)</label></disp-formula>
where <bold>Y</bold> = (<italic>Y</italic><sub>1</sub>, …, <italic>Y</italic><sub><italic>n</italic></sub>)′ is the training data outcome, <inline-formula id="pcbi.1008837.e018"><alternatives><graphic xlink:href="pcbi.1008837.e018.jpg" id="pcbi.1008837.e018g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M18"><mml:mrow><mml:msup><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>*</mml:mo></mml:msup><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mi>Y</mml:mi><mml:mn>1</mml:mn><mml:mo>*</mml:mo></mml:msubsup><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mi>Y</mml:mi><mml:mi>m</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> is the observed outcome in the evaluation set and <inline-formula id="pcbi.1008837.e019"><alternatives><graphic xlink:href="pcbi.1008837.e019.jpg" id="pcbi.1008837.e019g" mimetype="image" position="anchor" orientation="portrait"/><mml:math id="M19"><mml:mrow><mml:mover accent="true"><mml:mi mathvariant="bold">Y</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mo>=</mml:mo><mml:msup><mml:mrow><mml:mo>(</mml:mo><mml:msubsup><mml:mover accent="true"><mml:mi>Y</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mn>1</mml:mn><mml:mo>*</mml:mo></mml:msubsup><mml:mo>,</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>.</mml:mo><mml:mo>,</mml:mo><mml:msubsup><mml:mover accent="true"><mml:mi>Y</mml:mi><mml:mo>^</mml:mo></mml:mover><mml:mi>m</mml:mi><mml:mo>*</mml:mo></mml:msubsup><mml:mo>)</mml:mo></mml:mrow><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:math></alternatives></inline-formula> is the prediction for <bold>Y</bold>* to be evaluated [<xref rid="pcbi.1008837.ref108" ref-type="bibr">108</xref>]. MASE is scale invariant, which makes comparisons of predictive accuracy between states with epidemics on different scales more meaningful. A MASE of 1 indicates that the predictions were on average equally accurate to the mean accuracy of a random walk forecast in the training data. This is a somewhat conservative estimator of prediction error for COVID-19, because cases and deaths have generally increased with time, which means the MAE of a random walk forecast in the training data will be lower than the MAE of a random walk forecast in the subsequent evaluation data.</p>
                <p><xref ref-type="fig" rid="pcbi.1008837.g004">Fig 4</xref> depicts the median and interquartile range of MASE across states for cases and deaths over a three-week forecast after each of the training periods. As expected, the median and interquartile range of the MASE increased for both cases and deaths as forecasts extrapolated farther from the training data, although this increase is only slight for deaths. The model predicted cases and deaths reasonably well in light of the conservativeness of the estimator, especially within the first week of extrapolation, with the median MASE mostly below 1. The model forecasts deaths over this period particularly well, with only slightly diminished accuracy at 21 days. This is due at least in part to the lagged relationship between cases and deaths, which makes case data much more informative for a 3-week death forecast than for a 3-week case forecast.</p>
                <fig id="pcbi.1008837.g004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pcbi.1008837.g004</object-id>
                  <label>Fig 4</label>
                  <caption>
                    <title>Predictive accuracy.</title>
                    <p>The median and interquartile range (IQR) of MASE across all 50 states on each day of the 21-day prediction periods for new confirmed cases (a) and deaths (b). A MASE of 1 indicates equivalent accuracy to a one-day random walk forecast in the training data.</p>
                  </caption>
                  <graphic xlink:href="pcbi.1008837.g004"/>
                </fig>
                <p>As an additional test of the death model’s predictive accuracy, we compared it with a state-specific autoregressive (AR-1) model over the same 4 training and evaluation sets. The random forest death model predicted deaths more accurately than the AR-1 model for 3 of these 4 sets. The details of this evaluation may be found in <xref ref-type="supplementary-material" rid="pcbi.1008837.s004">S2 Table</xref>.</p>
              </sec>
            </sec>
            <sec id="sec009">
              <title>Results &amp; discussion</title>
              <p>Infections and deaths were projected through April 1, 2021, for all 50 states. <xref ref-type="fig" rid="pcbi.1008837.g005">Fig 5</xref> depicts median predicted cumulative confirmed cases as well as active confirmed infections and daily death counts for New York, Colorado, and West Virginia. These three states were selected as examples, because they are diverse in their population size, geography, political alignment, demographics, and in the progression of their COVID-19 epidemics. The equivalent figures for all 50 states are included in <xref ref-type="supplementary-material" rid="pcbi.1008837.s002">S2 Appendix</xref>.</p>
              <fig id="pcbi.1008837.g005" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pcbi.1008837.g005</object-id>
                <label>Fig 5</label>
                <caption>
                  <title>Predicted cumulative cases, active infections, deaths, and effective <italic>R</italic><sub><italic>t</italic></sub>.</title>
                  <p>Projected cumulative case count, active confirmed infections, and daily deaths through April 1, 2021, for New York, Colorado, and West Virginia. The grey dots indicate observed data, which are not available for active infections and <italic>R</italic><sub><italic>t</italic></sub>.</p>
                </caption>
                <graphic xlink:href="pcbi.1008837.g005"/>
              </fig>
              <p>New York, especially New York City with its large, dense population, was the epicenter of a large, early COVID-19 outbreak in the United States with over 300,000 confirmed cases by late April. Initial exponential case growth was slowly curbed by public interventions, leading to a consistent decrease in case velocity and peaks in active cases and deaths in mid April. Case growth being well past its peak translates into a plateaued cumulative case curve, which began to increase again in late 2020.</p>
              <p>Colorado, in contrast, has had many fewer cases than New York with approximately 350,000 cases by the end of 2020. Rather than exhibiting a sharp peak followed by low case growth, Colorado cases exhibit a steady climb punctuated by waves of faster and slower growth. Its interval estimates are relatively wider than New York, because there is more uncertainty in the estimated trajectory. Colorado also exhibits more relative variation in its daily death counts than New York because of the smaller number.</p>
              <p>West Virginia approaching 100,000 cases through the end of 2020 illustrates the estimated trajectories of a relatively rural state with slow case growth for the first few months of the pandemic, now showing signs of exponential growth. With cases growing more rapidly, there is correspondingly more relative uncertainty in its trajectory.</p>
              <p>The figures include 95% credible intervals around the median indicating that 95% of simulation results fell within this region. These intervals are not true credible intervals in the Bayesian sense, because random forest is not a probability model. Nevertheless, they represent a reasonable account of model uncertainty, as they incorporate credible intervals from the Bayesian case model, uncertainty around the duration of illness, and interval estimates for the random forest predictions.</p>
              <p>These forecasts extrapolate foward the trajectory of the pandemic at the end of 2020, but its future depends upon the ongoing societal and political response to the pandemic, and will be altered by future events. For example, aggressive lockdowns have been used to blunt case trajectories as in many other countries. Similarly vaccinations and newly developed treatments will substantially impact the number of new cases or deaths.</p>
              <p>Despite the strengths of the current approach, it is not without limitations. The projections produced here assume states continue upon their current trajectories. Changes in policy interventions, for example, may result in substantial deviation from this. Projecting outcomes under different or changing intervention scenarios is the subject of ongoing work.</p>
              <p>Considering COVID-19 cases and death over large areas can obscure variation on a smaller scale. It is possible for a generally positive trajectory at the state-level to mask a burgeoning outbreak in some locale within the state until that outbreak contributes sufficiently many cases to influence the state-wide trajectory. A more granular approach that models COVID-19 at a finer resolution may be able to identify such an outbreak earlier.</p>
              <p>There is substantial interest in estimating the proportion of the population that has or will have recovered from COVID-19 in the hopes that these individuals have acquired at least temporary immunity to the virus and can be the vanguard to economic recovery. Since we focus on modeling confirmed cases and deaths, our model does not predict the true number of recovered individuals. It is well known that, especially in the U.S., confirmed cases are a substantial undercount for the true number of COVID-19 infections. As a result, estimating the number of recovered individuals requires additional information beyond predictions of confirmed cases and deaths. Attempts to quantify recovery using serology testing are underway in the U.S. and elsewhere.</p>
              <p>Without the addition of covariates, the time series velocity model may not predict future case spikes, which may result from a return to pre-social distancing behavior or a change in governmental intervention. It does, however, accommodate these types of events quite well. The increasing velocity associated with a spike in cases corresponds to exponential growth at an increasing exponential rate. This rapidly causes an explosion of cases that pushes case growth beyond whatever level a particular population deems tolerable. In every case there has been a subsequent return to a velocity that corresponds to a tolerable level of case growth. By targeting this velocity, our model forecasts reasonable long-term case trajectories without needing to predict the occurrence of case spikes, which are quite difficult to anticipate precisely.</p>
              <p>Finally, one could consider more elegant methods for incorporating lagged case and death counts into a death model than simply inserting them as covariates into random forest. However, many approaches to lag estimation are only good retrospectively and thus are insufficient for the current task.</p>
              <p>This modeling framework suggests a number of avenues for future work. The most salient of these is the simulation of various scenarios that model policy or public health responses to the pandemic including the effects of vaccinations. Forecasting COVID-19 cases and deaths under alternate scenarios may provide useful information for decision makers. Future methodological improvements could include integrating all the components of the model within a single Bayesian model by substituting Bayesian additive regression trees (BART) for the random forest death model. This would provide a posterior distribution for all parameters and forecasts.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec010">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pcbi.1008837.s001">
                <label>S1 Appendix</label>
                <caption>
                  <title>Derivation of case transition function.</title>
                  <p>The derivation of the compartmental model transition function from the autoregressive velocity model.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pcbi.1008837.s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pcbi.1008837.s002">
                <label>S2 Appendix</label>
                <caption>
                  <title>State forecasts.</title>
                  <p>Projected cumulative case count, active confirmed infections, and daily deaths through April 1, 2021, for each of the 50 U.S. states.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pcbi.1008837.s002.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pcbi.1008837.s003">
                <label>S1 Table</label>
                <caption>
                  <title>Parameter values &amp; distributions.</title>
                  <p>The parameter values and prior distributions for the parameters of each component of the model.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pcbi.1008837.s003.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
              <supplementary-material content-type="local-data" id="pcbi.1008837.s004">
                <label>S2 Table</label>
                <caption>
                  <title>Death model comparison.</title>
                  <p>A comparison of the random forest death model to a state-specific autoregressive model over 4 different training and evaluation sets.</p>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pcbi.1008837.s004.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack>
              <p>We thank Donatello Telesca, Jay J. Xu, and Ian Frankenburg (University of California, Los Angeles) for their helpful comments and assistance.</p>
            </ack>
            <ref-list>
              <title>References</title>
              <ref id="pcbi.1008837.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>R</given-names></name>, <name><surname>Pei</surname><given-names>S</given-names></name>, <name><surname>Chen</surname><given-names>B</given-names></name>, <name><surname>Song</surname><given-names>Y</given-names></name>, <name><surname>Zhang</surname><given-names>T</given-names></name>, <name><surname>Yang</surname><given-names>W</given-names></name>, <etal>et al</etal>. <article-title>Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2)</article-title>. <source>Science</source>. <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Prem</surname><given-names>K</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Russell</surname><given-names>TW</given-names></name>, <name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Eggo</surname><given-names>RM</given-names></name>, <name><surname>Davies</surname><given-names>N</given-names></name>, <etal>et al</etal>. <article-title>The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study</article-title>. <source>Lancet Public Health</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/S2468-2667(20)30073-6</pub-id><?supplied-pmid 32220655?><pub-id pub-id-type="pmid">32220655</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Walker</surname><given-names>PG</given-names></name>, <name><surname>Whittaker</surname><given-names>C</given-names></name>, <name><surname>Watson</surname><given-names>O</given-names></name>, <name><surname>Baguelin</surname><given-names>M</given-names></name>, <name><surname>Ainslie</surname><given-names>K</given-names></name>, <name><surname>Bhatia</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>The global impact of COVID-19 and strategies for mitigation and suppression</article-title>. <source>Imperial College London</source>. <year>2020</year>; <pub-id pub-id-type="doi">10.1126/science.abc0035</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>Q</given-names></name>, <name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Gao</surname><given-names>D</given-names></name>, <name><surname>Lou</surname><given-names>Y</given-names></name>, <name><surname>Yang</surname><given-names>S</given-names></name>, <name><surname>Musa</surname><given-names>SS</given-names></name>, <etal>et al</etal>. <article-title>A conceptual model for the coronavirus disease 2019 (COVID-19) outbreak in Wuhan, China with individual reaction and governmental action</article-title>. <source>Int J Infect Dis</source>. <year>2020</year>;<volume>93</volume>:<fpage>211</fpage>–<lpage>216</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.02.058</pub-id>
<?supplied-pmid 32145465?><pub-id pub-id-type="pmid">32145465</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Mandal</surname><given-names>S</given-names></name>, <name><surname>Bhatnagar</surname><given-names>T</given-names></name>, <name><surname>Arinaminpathy</surname><given-names>N</given-names></name>, <name><surname>Agarwal</surname><given-names>A</given-names></name>, <name><surname>Chowdhury</surname><given-names>A</given-names></name>, <name><surname>Murhekar</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Prudent public health intervention strategies to control the coronavirus disease 2019 transmission in India: A mathematical model-based approach</article-title>. <source>Indian J Med Res</source>. <year>2020</year>;<volume>151</volume>. <pub-id pub-id-type="doi">10.4103/ijmr.IJMR_504_20</pub-id><?supplied-pmid 32362645?><pub-id pub-id-type="pmid">32362645</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Chatterjee</surname><given-names>K</given-names></name>, <name><surname>Chatterjee</surname><given-names>K</given-names></name>, <name><surname>Kumar</surname><given-names>A</given-names></name>, <name><surname>Shankar</surname><given-names>S</given-names></name>. <article-title>Healthcare impact of COVID-19 epidemic in India: A stochastic mathematical model</article-title>. <source>Med J Armed Forces India</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/j.mjafi.2020.03.022</pub-id><?supplied-pmid 32292232?><pub-id pub-id-type="pmid">32292232</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Kissler</surname><given-names>SM</given-names></name>, <name><surname>Tedijanto</surname><given-names>C</given-names></name>, <name><surname>Goldstein</surname><given-names>E</given-names></name>, <name><surname>Grad</surname><given-names>YH</given-names></name>, <name><surname>Lipsitch</surname><given-names>M</given-names></name>. <article-title>Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period</article-title>. <source>Science</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1126/science.abb5793</pub-id><?supplied-pmid 32291278?><pub-id pub-id-type="pmid">32291278</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>Eikenberry</surname><given-names>SE</given-names></name>, <name><surname>Mancuso</surname><given-names>M</given-names></name>, <name><surname>Iboi</surname><given-names>E</given-names></name>, <name><surname>Phan</surname><given-names>T</given-names></name>, <name><surname>Eikenberry</surname><given-names>K</given-names></name>, <name><surname>Kuang</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>To mask or not to mask: Modeling the potential for face mask use by the general public to curtail the COVID-19 pandemic</article-title>. <source>Infect Dis Model</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/j.idm.2020.04.001</pub-id><?supplied-pmid 32355904?><pub-id pub-id-type="pmid">32355904</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>Rocklöv</surname><given-names>J</given-names></name>, <name><surname>Sjödin</surname><given-names>H</given-names></name>, <name><surname>Wilder-Smith</surname><given-names>A</given-names></name>. <article-title>COVID-19 outbreak on the Diamond Princess cruise ship: estimating the epidemic potential and effectiveness of public health countermeasures</article-title>. <source>J Travel Med</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1093/jtm/taaa030</pub-id><?supplied-pmid 32109273?><pub-id pub-id-type="pmid">32109273</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref010">
                <label>10</label>
                <mixed-citation publication-type="other">Perkins A, Espana G. Optimal control of the COVID-19 pandemic with non-pharmaceutical interventions. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref011">
                <label>11</label>
                <mixed-citation publication-type="other">González RE. Different scenarios in the dynamics of SARS-CoV-2 infection: an adapted ODE model. arXiv:200401295. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Tuite</surname><given-names>AR</given-names></name>, <name><surname>Fisman</surname><given-names>DN</given-names></name>, <name><surname>Greer</surname><given-names>AL</given-names></name>. <article-title>Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada</article-title>. <source>CMAJ</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1503/cmaj.200476</pub-id><?supplied-pmid 32269018?><pub-id pub-id-type="pmid">32269018</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Berger</surname><given-names>DW</given-names></name>, <name><surname>Herkenhoff</surname><given-names>KF</given-names></name>, <name><surname>Mongey</surname><given-names>S</given-names></name>. <article-title>An SEIR infectious disease model with testing and conditional quarantine</article-title>. <source>National Bureau of Economic Research</source>; <year>2020</year>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>Matrajt</surname><given-names>L</given-names></name>, <name><surname>Leung</surname><given-names>T</given-names></name>. <article-title>Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease</article-title>. <source>J Emerg Infect Dis</source>. <year>2020</year>;<volume>26</volume>(<issue>8</issue>). <pub-id pub-id-type="doi">10.3201/eid2608.201093</pub-id><?supplied-pmid 32343222?><pub-id pub-id-type="pmid">32343222</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>C</given-names></name>, <name><surname>Wang</surname><given-names>J</given-names></name>. <article-title>A mathematical model for the novel coronavirus epidemic in Wuhan, China</article-title>. <source>Math Biosci Eng</source>. <year>2020</year>;<volume>17</volume>(<issue>3</issue>):<fpage>2708</fpage>–<lpage>2724</lpage>. <pub-id pub-id-type="doi">10.3934/mbe.2020148</pub-id>
<?supplied-pmid 32233562?><pub-id pub-id-type="pmid">32233562</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Gostic</surname><given-names>K</given-names></name>, <name><surname>Gomez</surname><given-names>AC</given-names></name>, <name><surname>Mummah</surname><given-names>RO</given-names></name>, <name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Lloyd-Smith</surname><given-names>JO</given-names></name>. <article-title>Estimated effectiveness of symptom and risk screening to prevent the spread of COVID-19</article-title>. <source>Elife</source>. <year>2020</year>;<volume>9</volume>:<fpage>e55570</fpage>. <pub-id pub-id-type="doi">10.7554/eLife.55570</pub-id><?supplied-pmid 32091395?><pub-id pub-id-type="pmid">32091395</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Wang</surname><given-names>Z</given-names></name>, <name><surname>Dong</surname><given-names>Y</given-names></name>, <name><surname>Chang</surname><given-names>R</given-names></name>, <name><surname>Xu</surname><given-names>C</given-names></name>, <name><surname>Yu</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>Phase-adjusted estimation of the number of coronavirus disease 2019 cases in Wuhan, China</article-title>. <source>Cell Discov</source>. <year>2020</year>;<volume>6</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1038/s41421-020-0148-0</pub-id><pub-id pub-id-type="pmid">31934347</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref018">
                <label>18</label>
                <mixed-citation publication-type="other">Pei S, Shaman J. Initial simulation of SARS-CoV2 spread and intervention effects in the continental US. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref019">
                <label>19</label>
                <mixed-citation publication-type="other">Ranjan R. Predictions for COVID-19 outbreak in India using epidemiological models. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref020">
                <label>20</label>
                <mixed-citation publication-type="other">Calafiore GC, Novara C, Possieri C. A Modified SIR Model for the COVID-19 Contagion in Italy. arXiv:200314391. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref021">
                <label>21</label>
                <mixed-citation publication-type="other">Peng L, Yang W, Zhang D, Zhuge C, Hong L. Epidemic analysis of COVID-19 in China by dynamical modeling. arXiv:200206563. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref022">
                <label>22</label>
                <mixed-citation publication-type="other">Manou-Abu S, Balicchi J. Analysis of the COVID-19 epidemic in french overseas department Mayotte based on a modified deterministic and stochastic SEIR model. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Kuniya</surname><given-names>T</given-names></name>. <article-title>Prediction of the epidemic peak of coronavirus Disease in Japan, 2020</article-title>. <source>J Clin Med</source>. <year>2020</year>;<volume>9</volume>(<issue>3</issue>):<fpage>789</fpage>. <pub-id pub-id-type="doi">10.3390/jcm9030789</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref024">
                <label>24</label>
                <mixed-citation publication-type="other">Simha A, Prasad RV, Narayana S. A simple Stochastic SIR model for COVID-19 Infection Dynamics for Karnataka: Learning from Europe. arXiv:200311920. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref025">
                <label>25</label>
                <mixed-citation publication-type="other">Lopez LR, Rodo X. A modified SEIR model to predict the COVID-19 outbreak in Spain and Italy: simulating control scenarios and multi-scale epidemics. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref026">
                <label>26</label>
                <mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>S</given-names></name>, <name><surname>Ki</surname><given-names>M</given-names></name>. <article-title>Estimating the reproductive number and the outbreak size of novel coronavirus disease (COVID-19) using mathematical model in Republic of Korea</article-title>. <source>Epidemiol Health</source>. <year>2020</year>; p. <fpage>e2020011</fpage>. <pub-id pub-id-type="doi">10.4178/epih.e2020011</pub-id><?supplied-pmid 32164053?><pub-id pub-id-type="pmid">32164053</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Kim</surname><given-names>YJ</given-names></name>, <name><surname>Peck</surname><given-names>KR</given-names></name>, <name><surname>Jung</surname><given-names>E</given-names></name>. <article-title>School opening delay effect on transmission dynamics of coronavirus disease 2019 in Korea: based on mathematical modeling and simulation study</article-title>. <source>J Korean Med Sci</source>. <year>2020</year>;<volume>35</volume>(<issue>13</issue>). <pub-id pub-id-type="doi">10.3346/jkms.2020.35.e143</pub-id><?supplied-pmid 32242349?><pub-id pub-id-type="pmid">32242349</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref028">
                <label>28</label>
                <mixed-citation publication-type="other">Pandey G, Chaudhary P, Gupta R, Pal S. SEIR and regression model based COVID-19 outbreak predictions in India. arXiv:200400958. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Anastassopoulou</surname><given-names>C</given-names></name>, <name><surname>Russo</surname><given-names>L</given-names></name>, <name><surname>Tsakris</surname><given-names>A</given-names></name>, <name><surname>Siettos</surname><given-names>C</given-names></name>. <article-title>Data-based analysis, modelling and forecasting of the COVID-19 outbreak</article-title>. <source>PloS one</source>. <year>2020</year>;<volume>15</volume>(<issue>3</issue>):<fpage>e0230405</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0230405</pub-id><?supplied-pmid 32231374?><pub-id pub-id-type="pmid">32231374</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref030">
                <label>30</label>
                <mixed-citation publication-type="other">Crokidakis N. Data analysis and modeling of the evolution of COVID-19 in Brazil. arXiv preprint arXiv:200312150. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Ndaïrou</surname><given-names>F</given-names></name>, <name><surname>Area</surname><given-names>I</given-names></name>, <name><surname>Nieto</surname><given-names>JJ</given-names></name>, <name><surname>Torres</surname><given-names>DF</given-names></name>. <article-title>Mathematical Modeling of COVID-19 Transmission Dynamics with a Case Study of Wuhan</article-title>. <source>Chaos Solitons Fractals</source>. <year>2020</year>; p. <fpage>109846</fpage>. <pub-id pub-id-type="doi">10.1016/j.chaos.2020.109846</pub-id><?supplied-pmid 32341628?><pub-id pub-id-type="pmid">32341628</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>S</given-names></name>, <name><surname>Seo</surname><given-names>YB</given-names></name>, <name><surname>Jung</surname><given-names>E</given-names></name>. <article-title>Prediction of COVID-19 transmission dynamics using a mathematical model considering behavior changes</article-title>. <source>Epidemiol Health</source>. <year>2020</year>; p. <fpage>e2020026</fpage>. <pub-id pub-id-type="doi">10.4178/epih.e2020026</pub-id><?supplied-pmid 32375455?><pub-id pub-id-type="pmid">32375455</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Magal</surname><given-names>P</given-names></name>, <name><surname>Seydi</surname><given-names>O</given-names></name>, <name><surname>Webb</surname><given-names>G</given-names></name>. <article-title>Understanding unreported cases in the COVID-19 epidemic outbreak in Wuhan, China, and the importance of major public health interventions</article-title>. <source>Biology</source>. <year>2020</year>;<volume>9</volume>(<issue>3</issue>):<fpage>50</fpage>. <pub-id pub-id-type="doi">10.3390/biology9030050</pub-id><?supplied-pmid 32182724?><pub-id pub-id-type="pmid">32182724</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>TM</given-names></name>, <name><surname>Rui</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>QP</given-names></name>, <name><surname>Zhao</surname><given-names>ZY</given-names></name>, <name><surname>Cui</surname><given-names>JA</given-names></name>, <name><surname>Yin</surname><given-names>L</given-names></name>. <article-title>A mathematical model for simulating the phase-based transmissibility of a novel coronavirus</article-title>. <source>Infect Dis Poverty</source>. <year>2020</year>;<volume>9</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>8</lpage>. <pub-id pub-id-type="doi">10.1186/s40249-020-00640-3</pub-id>
<?supplied-pmid 32111262?><pub-id pub-id-type="pmid">31996251</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Hu</surname><given-names>Z</given-names></name>, <name><surname>Cui</surname><given-names>Q</given-names></name>, <name><surname>Han</surname><given-names>J</given-names></name>, <name><surname>Wang</surname><given-names>X</given-names></name>, <name><surname>Wei</surname><given-names>E</given-names></name>, <name><surname>Teng</surname><given-names>Z</given-names></name>. <article-title>Evaluation and prediction of the COVID-19 variations at different input population and quarantine strategies, a case study in Guangdong province, China</article-title>. <source>Int J Infect Dis</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.04.010</pub-id><?supplied-pmid 32334117?><pub-id pub-id-type="pmid">32334117</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>S</given-names></name>, <name><surname>Song</surname><given-names>K</given-names></name>, <name><surname>Yang</surname><given-names>B</given-names></name>, <name><surname>Gao</surname><given-names>Y</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>. <article-title>Preliminary Assessment of the COVID-19 Outbreak Using 3-Staged Model e-ISHR</article-title>. <source>J Shanghai Jiaotong Univ Sci</source>. <year>2020</year>;<volume>25</volume>:<fpage>157</fpage>–<lpage>164</lpage>. <pub-id pub-id-type="doi">10.1007/s12204-020-2169-0</pub-id>
<?supplied-pmid 32288417?><pub-id pub-id-type="pmid">32288417</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>K</given-names></name>, <name><surname>Liu</surname><given-names>H</given-names></name>, <name><surname>Gao</surname><given-names>Y</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>. <article-title>CIRD-F: Spread and Influence of COVID-19 in China</article-title>. <source>J Shanghai Jiaotong Univ Sci</source>. <year>2020</year>;<volume>25</volume>:<fpage>147</fpage>–<lpage>156</lpage>. <pub-id pub-id-type="doi">10.1007/s12204-020-2168-1</pub-id>
<?supplied-pmid 32288416?><pub-id pub-id-type="pmid">32288416</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Wan</surname><given-names>K</given-names></name>, <name><surname>Chen</surname><given-names>J</given-names></name>, <name><surname>Lu</surname><given-names>C</given-names></name>, <name><surname>Dong</surname><given-names>L</given-names></name>, <name><surname>Wu</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>. <article-title>When will the battle against novel coronavirus end in Wuhan: A SEIR modeling analysis</article-title>. <source>J Glob Health</source>. <year>2020</year>;<volume>10</volume>(<issue>1</issue>). <pub-id pub-id-type="doi">10.7189/jogh.10.011002</pub-id><?supplied-pmid 32257174?><pub-id pub-id-type="pmid">32257174</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Wei</surname><given-names>Y</given-names></name>, <name><surname>Lu</surname><given-names>Z</given-names></name>, <name><surname>Du</surname><given-names>Z</given-names></name>, <name><surname>Zhang</surname><given-names>Z</given-names></name>, <name><surname>Zhao</surname><given-names>Y</given-names></name>, <name><surname>Shen</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Fitting and forecasting the trend of COVID-19 by SEIR (+ CAQ) dynamic model</article-title>. <source>Zhonghua Liu Xing Bing Xue Za Zhi</source>. <year>2020</year>;<volume>41</volume>(<issue>4</issue>):<fpage>470</fpage>–<lpage>475</lpage>. <?supplied-pmid 32113198?><pub-id pub-id-type="pmid">32113198</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Kucharski</surname><given-names>AJ</given-names></name>, <name><surname>Russell</surname><given-names>TW</given-names></name>, <name><surname>Diamond</surname><given-names>C</given-names></name>, <name><surname>Liu</surname><given-names>Y</given-names></name>, <name><surname>Edmunds</surname><given-names>J</given-names></name>, <name><surname>Funk</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>Early dynamics of transmission and control of COVID-19: a mathematical modelling study</article-title>. <source>Lancet Infect Dis</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30144-4</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>B</given-names></name>, <name><surname>Bragazzi</surname><given-names>NL</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Tang</surname><given-names>S</given-names></name>, <name><surname>Xiao</surname><given-names>Y</given-names></name>, <name><surname>Wu</surname><given-names>J</given-names></name>. <article-title>An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)</article-title>. <source>Infect Dis Model</source>. <year>2020</year>;<volume>5</volume>:<fpage>248</fpage>–<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1016/j.idm.2020.02.001</pub-id>
<?supplied-pmid 32099934?><pub-id pub-id-type="pmid">32099934</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref042">
                <label>42</label>
                <mixed-citation publication-type="other">Dandekar R, Barbastathis G. Quantifying the effect of quarantine control in Covid-19 infectious spread using machine learning. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref043">
                <label>43</label>
                <mixed-citation publication-type="other">Osthus D, Del Valle S, Manore C, Michaud I, Weaver B, Castro L. COVID-19 confirmed and forecasted case data;. <ext-link ext-link-type="uri" xlink:href="https://covid-19.bsvgateway.org/">https://covid-19.bsvgateway.org/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref044">
                <label>44</label>
                <mixed-citation publication-type="other">Sun H, Qiu Y, Yan H, Huang Y, Zhu Y, Chen SX. Tracking and predicting COVID-19 epidemic in China mainland. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref045">
                <label>45</label>
                <mixed-citation publication-type="journal"><name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Zeng</surname><given-names>Z</given-names></name>, <name><surname>Wang</surname><given-names>K</given-names></name>, <name><surname>Wong</surname><given-names>SS</given-names></name>, <name><surname>Liang</surname><given-names>W</given-names></name>, <name><surname>Zanin</surname><given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Modified SEIR and AI prediction of the epidemics trend of COVID-19 in China under public health interventions</article-title>. <source>J Thorac Dis</source>. <year>2020</year>;<volume>12</volume>(<issue>3</issue>):<fpage>165</fpage>. <pub-id pub-id-type="doi">10.21037/jtd.2020.02.64</pub-id><?supplied-pmid 32274081?><pub-id pub-id-type="pmid">32274081</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref046">
                <label>46</label>
                <mixed-citation publication-type="other">Picchiotti N, Salvioli M, Zanardini E, Missale F. COVID-19 Italian and Europe epidemic evolution: A SEIR model with lockdown-dependent transmission rate based on Chinese data. Available at SSRN. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref047">
                <label>47</label>
                <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>Z</given-names></name>, <name><surname>Magal</surname><given-names>P</given-names></name>, <name><surname>Seydi</surname><given-names>O</given-names></name>, <name><surname>Webb</surname><given-names>G</given-names></name>. <article-title>A COVID-19 epidemic model with latency period</article-title>. <source>Infect Dis Model</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/j.idm.2020.03.003</pub-id><?supplied-pmid 32346664?><pub-id pub-id-type="pmid">32346664</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref048">
                <label>48</label>
                <mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>C</given-names></name>, <name><surname>Zhao</surname><given-names>J</given-names></name>, <name><surname>Liu</surname><given-names>G</given-names></name>, <name><surname>Gao</surname><given-names>Y</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>. <article-title>D 2 EA: Depict the Epidemic Picture of COVID-19</article-title>. <source>Journal of Shanghai Jiaotong University (Science)</source>. <year>2020</year>;<volume>25</volume>:<fpage>165</fpage>–<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1007/s12204-020-2170-7</pub-id>
<?supplied-pmid 32288418?><pub-id pub-id-type="pmid">32288418</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref049">
                <label>49</label>
                <mixed-citation publication-type="journal"><name><surname>Zhou</surname><given-names>W</given-names></name>, <name><surname>Wang</surname><given-names>A</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Xiao</surname><given-names>Y</given-names></name>, <name><surname>Tang</surname><given-names>S</given-names></name>. <article-title>Effects of media reporting on mitigating spread of COVID-19 in the early phase of the outbreak</article-title>. <source>Math Biosci Eng</source>. <year>2020</year>;<volume>17</volume>(<issue>3</issue>):<fpage>2693</fpage>. <pub-id pub-id-type="doi">10.3934/mbe.2020147</pub-id><?supplied-pmid 32233561?><pub-id pub-id-type="pmid">32233561</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref050">
                <label>50</label>
                <mixed-citation publication-type="journal"><name><surname>Tang</surname><given-names>B</given-names></name>, <name><surname>Xia</surname><given-names>F</given-names></name>, <name><surname>Tang</surname><given-names>S</given-names></name>, <name><surname>Bragazzi</surname><given-names>NL</given-names></name>, <name><surname>Li</surname><given-names>Q</given-names></name>, <name><surname>Sun</surname><given-names>X</given-names></name>, <etal>et al</etal>. <article-title>The effectiveness of quarantine and isolation determine the trend of the COVID-19 epidemics in the final phase of the current outbreak in China</article-title>. <source>Int J Infect Dis</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.03.018</pub-id><?supplied-pmid 32171948?><pub-id pub-id-type="pmid">32171948</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref051">
                <label>51</label>
                <mixed-citation publication-type="journal"><name><surname>Wu</surname><given-names>JT</given-names></name>, <name><surname>Leung</surname><given-names>K</given-names></name>, <name><surname>Leung</surname><given-names>GM</given-names></name>. <article-title>Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study</article-title>. <source>Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10225</issue>):<fpage>689</fpage>–<lpage>697</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30260-9</pub-id>
<?supplied-pmid 32014114?><pub-id pub-id-type="pmid">32014114</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref052">
                <label>52</label>
                <mixed-citation publication-type="other">Vespignani A, Chinazzi M, Davis JT, Mu K, y Piontti AP, Samay N, et al. Modeling of COVID-19 epidemic in the United States;. <ext-link ext-link-type="uri" xlink:href="https://uploads-ssl.webflow.com/58e6558acc00ee8e4536c1f5/5e8bab44f5baae4c1c2a75d2_GLEAM_web.pdf">https://uploads-ssl.webflow.com/58e6558acc00ee8e4536c1f5/5e8bab44f5baae4c1c2a75d2_GLEAM_web.pdf</ext-link>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref053">
                <label>53</label>
                <mixed-citation publication-type="other">Yuan GX, Di L, Gu Y, Qian G, Qian X. The framework for the prediction of the critical turning period for outbreak of COVID-19 spread in China based on the iSEIR Model. arXiv:200402278. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref054">
                <label>54</label>
                <mixed-citation publication-type="other">Wodarz D, Komarova NL. Patterns of the COVID19 epidemic spread around the world: exponential vs power laws. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref055">
                <label>55</label>
                <mixed-citation publication-type="other">Zahiri A, RafieeNasab S, Roohi E. Prediction of peak and termination of novel coronavirus Covid-19 epidemic in Iran. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref056">
                <label>56</label>
                <mixed-citation publication-type="journal"><name><surname>Chinazzi</surname><given-names>M</given-names></name>, <name><surname>Davis</surname><given-names>JT</given-names></name>, <name><surname>Ajelli</surname><given-names>M</given-names></name>, <name><surname>Gioannini</surname><given-names>C</given-names></name>, <name><surname>Litvinova</surname><given-names>M</given-names></name>, <name><surname>Merler</surname><given-names>S</given-names></name>, <etal>et al</etal>. <article-title>The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak</article-title>. <source>Science</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1126/science.aba9757</pub-id><?supplied-pmid 32144116?><pub-id pub-id-type="pmid">32144116</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref057">
                <label>57</label>
                <mixed-citation publication-type="other">Arenas A, Cota W, Gomez-Gardenes J, Gómez S, Granell C, Matamalas JT, et al. A mathematical model for the spatiotemporal epidemic spreading of COVID19. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref058">
                <label>58</label>
                <mixed-citation publication-type="other">Ke R, Sanche S, Romero-Severson E, Hengartner N. Fast spread of COVID-19 in Europe and the US suggests the necessity of early, strong and comprehensive interventions. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref059">
                <label>59</label>
                <mixed-citation publication-type="journal"><name><surname>Ivorra</surname><given-names>B</given-names></name>, <name><surname>Ferrández</surname><given-names>MR</given-names></name>, <name><surname>Vela-Pérez</surname><given-names>M</given-names></name>, <name><surname>Ramos</surname><given-names>A</given-names></name>. <article-title>Mathematical modeling of the spread of the coronavirus disease 2019 (COVID-19) taking into account the undetected infections</article-title>. <source>The case of China. Commun Nonlinear Sci Numer Simul</source>. <year>2020</year>; p. <fpage>105303</fpage>. <pub-id pub-id-type="doi">10.1016/j.cnsns.2020.105303</pub-id><?supplied-pmid 32355435?><pub-id pub-id-type="pmid">32355435</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref060">
                <label>60</label>
                <mixed-citation publication-type="journal"><name><surname>Arino</surname><given-names>J</given-names></name>, <name><surname>Portet</surname><given-names>S</given-names></name>. <article-title>A simple model for COVID-19</article-title>. <source>Infect Dis Model</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/j.idm.2020.04.002</pub-id><?supplied-pmid 32346663?><pub-id pub-id-type="pmid">32346663</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref061">
                <label>61</label>
                <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>G</given-names></name>, <name><surname>Pan</surname><given-names>Q</given-names></name>, <name><surname>Zhao</surname><given-names>S</given-names></name>, <name><surname>Gao</surname><given-names>Y</given-names></name>, <name><surname>Gao</surname><given-names>X</given-names></name>. <article-title>Prediction of COVID-19 Outbreak in China and Optimal Return Date for University Students Based on Propagation Dynamics</article-title>. <source>J Shanghai Jiaotong Univ Sci</source>. <year>2020</year>;<volume>25</volume>:<fpage>140</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1007/s12204-020-2167-2</pub-id>
<?supplied-pmid 32288415?><pub-id pub-id-type="pmid">32288415</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref062">
                <label>62</label>
                <mixed-citation publication-type="book"><name><surname>Brauer</surname><given-names>F</given-names></name>, <name><surname>Castillo-Chavez</surname><given-names>C</given-names></name>, <name><surname>Castillo-Chavez</surname><given-names>C</given-names></name>. <source>Mathematical models in population biology and epidemiology</source>. <volume>vol. 2</volume>. <publisher-name>Springer</publisher-name>; <year>2012</year>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref063">
                <label>63</label>
                <mixed-citation publication-type="journal"><name><surname>Kermack</surname><given-names>WO</given-names></name>, <name><surname>McKendrick</surname><given-names>AG</given-names></name>. <article-title>A contribution to the mathematical theory of epidemics</article-title>. <source>Proceedings of the Royal Society of London Series A, Containing papers of a mathematical and physical character</source>. <year>1927</year>;<volume>115</volume>(<issue>772</issue>):<fpage>700</fpage>–<lpage>721</lpage>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref064">
                <label>64</label>
                <mixed-citation publication-type="other">Ferguson N, Laydon D, Nedjati Gilani G, Imai N, Ainslie K, Baguelin M, et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand. Imperial College London. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref065">
                <label>65</label>
                <mixed-citation publication-type="journal"><name><surname>Koo</surname><given-names>JR</given-names></name>, <name><surname>Cook</surname><given-names>AR</given-names></name>, <name><surname>Park</surname><given-names>M</given-names></name>, <name><surname>Sun</surname><given-names>Y</given-names></name>, <name><surname>Sun</surname><given-names>H</given-names></name>, <name><surname>Lim</surname><given-names>JT</given-names></name>, <etal>et al</etal>. <article-title>Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study</article-title>. <source>Lancet Infect Dis</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/S1473-3099(20)30162-6</pub-id><?supplied-pmid 32213332?><pub-id pub-id-type="pmid">32213332</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref066">
                <label>66</label>
                <mixed-citation publication-type="other">Chang SL, Harding N, Zachreson C, Cliff OM, Prokopenko M. Modelling transmission and control of the COVID-19 pandemic in Australia. arXiv:200310218. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref067">
                <label>67</label>
                <mixed-citation publication-type="other">Ruiz Estrada MA, Koutronas E. The Networks Infection Contagious Diseases Positioning System (NICDP-System): The Case of Wuhan-COVID-19. Available at SSRN 3548413. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref068">
                <label>68</label>
                <mixed-citation publication-type="other">Wilder B, Charpignon M, Killian JA, Ou HC, Mate A, Jabbari S, et al. The role of age distribution and family structure on covid-19 dynamics: A preliminary modeling assessment for Hubei and Lombardy. Available at SSRN 3564800. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref069">
                <label>69</label>
                <mixed-citation publication-type="journal"><name><surname>Mizumoto</surname><given-names>K</given-names></name>, <name><surname>Chowell</surname><given-names>G</given-names></name>. <article-title>Transmission potential of the novel coronavirus (COVID-19) onboard the Diamond Princess Cruises Ship, 2020</article-title>. <source>Infect Dis Model</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/j.idm.2020.02.003</pub-id><?supplied-pmid 32190785?><pub-id pub-id-type="pmid">32190785</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref070">
                <label>70</label>
                <mixed-citation publication-type="journal"><name><surname>Hellewell</surname><given-names>J</given-names></name>, <name><surname>Abbott</surname><given-names>S</given-names></name>, <name><surname>Gimma</surname><given-names>A</given-names></name>, <name><surname>Bosse</surname><given-names>NI</given-names></name>, <name><surname>Jarvis</surname><given-names>CI</given-names></name>, <name><surname>Russell</surname><given-names>TW</given-names></name>, <etal>et al</etal>. <article-title>Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts</article-title>. <source>Lancet Glob Health</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1016/S2214-109X(20)30074-7</pub-id><?supplied-pmid 32119825?><pub-id pub-id-type="pmid">32119825</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref071">
                <label>71</label>
                <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>S</given-names></name>, <name><surname>Diao</surname><given-names>M</given-names></name>, <name><surname>Yu</surname><given-names>W</given-names></name>, <name><surname>Pei</surname><given-names>L</given-names></name>, <name><surname>Lin</surname><given-names>Z</given-names></name>, <name><surname>Chen</surname><given-names>D</given-names></name>. <article-title>Estimation of the reproductive number of novel coronavirus (COVID-19) and the probable outbreak size on the Diamond Princess cruise ship: A data-driven analysis</article-title>. <source>Int J Infect Dis</source>. <year>2020</year>;<volume>93</volume>:<fpage>201</fpage>–<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijid.2020.02.033</pub-id>
<?supplied-pmid 32097725?><pub-id pub-id-type="pmid">32097725</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref072">
                <label>72</label>
                <mixed-citation publication-type="journal"><name><surname>Li</surname><given-names>L</given-names></name>, <name><surname>Yang</surname><given-names>Z</given-names></name>, <name><surname>Dang</surname><given-names>Z</given-names></name>, <name><surname>Meng</surname><given-names>C</given-names></name>, <name><surname>Huang</surname><given-names>J</given-names></name>, <name><surname>Meng</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Propagation analysis and prediction of the COVID-19</article-title>. <source>Infect Dis Model</source>. <year>2020</year>;<volume>5</volume>:<fpage>282</fpage>–<lpage>292</lpage>. <pub-id pub-id-type="doi">10.1016/j.idm.2020.03.002</pub-id>
<?supplied-pmid 32292868?><pub-id pub-id-type="pmid">32292868</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref073">
                <label>73</label>
                <mixed-citation publication-type="journal"><name><surname>Kraemer</surname><given-names>MU</given-names></name>, <name><surname>Yang</surname><given-names>CH</given-names></name>, <name><surname>Gutierrez</surname><given-names>B</given-names></name>, <name><surname>Wu</surname><given-names>CH</given-names></name>, <name><surname>Klein</surname><given-names>B</given-names></name>, <name><surname>Pigott</surname><given-names>DM</given-names></name>, <etal>et al</etal>. <article-title>The effect of human mobility and control measures on the COVID-19 epidemic in China</article-title>. <source>Science</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.1126/science.abb4218</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref074">
                <label>74</label>
                <mixed-citation publication-type="other">Wu K, Darcet D, Wang Q, Sornette D. Generalized logistic growth modeling of the COVID-19 outbreak in 29 provinces in China and in the rest of the world. arXiv:200305681. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref075">
                <label>75</label>
                <mixed-citation publication-type="other">Ding G, Li X, Shen Y, Fan J. Brief analysis of the ARIMA model on the COVID-19 in Italy. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref076">
                <label>76</label>
                <mixed-citation publication-type="journal"><name><surname>Benvenuto</surname><given-names>D</given-names></name>, <name><surname>Giovanetti</surname><given-names>M</given-names></name>, <name><surname>Vassallo</surname><given-names>L</given-names></name>, <name><surname>Angeletti</surname><given-names>S</given-names></name>, <name><surname>Ciccozzi</surname><given-names>M</given-names></name>. <article-title>Application of the ARIMA model on the COVID-2019 epidemic dataset</article-title>. <source>Data Brief</source>. <year>2020</year>; p. <fpage>105340</fpage>. <pub-id pub-id-type="doi">10.1016/j.dib.2020.105340</pub-id><?supplied-pmid 32181302?><pub-id pub-id-type="pmid">32181302</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref077">
                <label>77</label>
                <mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>X</given-names></name>, <name><surname>Yu</surname><given-names>B</given-names></name>. <article-title>First two months of the 2019 Coronavirus Disease (COVID-19) epidemic in China: real-time surveillance and evaluation with a second derivative model</article-title>. <source>Glob Health Res Policy</source>. <year>2020</year>;<volume>5</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1186/s41256-020-00137-4</pub-id>
<?supplied-pmid 32158961?><pub-id pub-id-type="pmid">31956697</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref078">
                <label>78</label>
                <mixed-citation publication-type="journal"><name><surname>Ciufolini</surname><given-names>I</given-names></name>, <name><surname>Paolozzi</surname><given-names>A</given-names></name>. <article-title>Mathematical prediction of the time evolution of the COVID-19 pandemic in Italy by a Gauss error function and Monte Carlo simulations</article-title>. <source>Eur Phys J Plus</source>. <year>2020</year>;<volume>135</volume>(<issue>4</issue>):<fpage>355</fpage>. <pub-id pub-id-type="doi">10.1140/epjp/s13360-020-00383-y</pub-id><?supplied-pmid 32309108?><pub-id pub-id-type="pmid">32309108</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref079">
                <label>79</label>
                <mixed-citation publication-type="other">Xu H, Yuan M, Ma L, Liu M, Zhang Y, Liu W, et al. Basic reproduction number of 2019 novel coronavirus Disease in major endemic areas of China: A latent profile analysis. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref080">
                <label>80</label>
                <mixed-citation publication-type="journal"><name><surname>Liang</surname><given-names>K</given-names></name>. <article-title>Mathematical model of infection kinetics and its analysis for COVID-19, SARS and MERS</article-title>. <source>Infect Genet Evol</source>. <year>2020</year>; p. <fpage>104306</fpage>. <pub-id pub-id-type="doi">10.1016/j.meegid.2020.104306</pub-id><?supplied-pmid 32278147?><pub-id pub-id-type="pmid">32278147</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref081">
                <label>81</label>
                <mixed-citation publication-type="journal"><name><surname>Huang</surname><given-names>R</given-names></name>, <name><surname>Liu</surname><given-names>M</given-names></name>, <name><surname>Ding</surname><given-names>Y</given-names></name>. <article-title>Spatial-temporal distribution of COVID-19 in China and its prediction: A data-driven modeling analysis</article-title>. <source>J Infect Dev Ctries</source>. <year>2020</year>;<volume>14</volume>(<issue>03</issue>):<fpage>246</fpage>–<lpage>253</lpage>. <pub-id pub-id-type="doi">10.3855/jidc.12585</pub-id>
<?supplied-pmid 32235084?><pub-id pub-id-type="pmid">32235084</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref082">
                <label>82</label>
                <mixed-citation publication-type="journal"><name><surname>Wang</surname><given-names>L</given-names></name>, <name><surname>Li</surname><given-names>J</given-names></name>, <name><surname>Guo</surname><given-names>S</given-names></name>, <name><surname>Xie</surname><given-names>N</given-names></name>, <name><surname>Yao</surname><given-names>L</given-names></name>, <name><surname>Cao</surname><given-names>Y</given-names></name>, <etal>et al</etal>. <article-title>Real-time estimation and prediction of mortality caused by COVID-19 with patient information based algorithm</article-title>. <source>Science of the Total Environment</source>. <year>2020</year>; p. <fpage>138394</fpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138394</pub-id><?supplied-pmid 32334207?><pub-id pub-id-type="pmid">32334207</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref083">
                <label>83</label>
                <mixed-citation publication-type="journal"><name><surname>Gupta</surname><given-names>S</given-names></name>, <name><surname>Raghuwanshi</surname><given-names>GS</given-names></name>, <name><surname>Chanda</surname><given-names>A</given-names></name>. <article-title>Effect of weather on COVID-19 spread in the US: A prediction model for India in 2020</article-title>. <source>Sci Total Environ</source>. <year>2020</year>; p. <fpage>138860</fpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138860</pub-id><?supplied-pmid 32334160?><pub-id pub-id-type="pmid">32334160</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref084">
                <label>84</label>
                <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>X</given-names></name>, <name><surname>Ma</surname><given-names>R</given-names></name>, <name><surname>Wang</surname><given-names>L</given-names></name>. <article-title>Predicting turning point, duration and attack rate of COVID-19 outbreaks in major Western countries</article-title>. <source>Chaos Solitons Fractals</source>. <year>2020</year>; p. <fpage>109829</fpage>. <pub-id pub-id-type="doi">10.1016/j.chaos.2020.109829</pub-id><?supplied-pmid 32313405?><pub-id pub-id-type="pmid">32313405</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref085">
                <label>85</label>
                <mixed-citation publication-type="journal"><name><surname>Petropoulos</surname><given-names>F</given-names></name>, <name><surname>Makridakis</surname><given-names>S</given-names></name>. <article-title>Forecasting the novel coronavirus COVID-19</article-title>. <source>PloS one</source>. <year>2020</year>;<volume>15</volume>(<issue>3</issue>):<fpage>e0231236</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0231236</pub-id><?supplied-pmid 32231392?><pub-id pub-id-type="pmid">32231392</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref086">
                <label>86</label>
                <mixed-citation publication-type="journal"><name><surname>Tomar</surname><given-names>A</given-names></name>, <name><surname>Gupta</surname><given-names>N</given-names></name>. <article-title>Prediction for the spread of COVID-19 in India and effectiveness of preventive measures</article-title>. <source>Sci Total Environ</source>. <year>2020</year>; p. <fpage>138762</fpage>. <pub-id pub-id-type="doi">10.1016/j.scitotenv.2020.138762</pub-id><?supplied-pmid 32334157?><pub-id pub-id-type="pmid">32334157</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref087">
                <label>87</label>
                <mixed-citation publication-type="journal"><name><surname>Tiwari</surname><given-names>S</given-names></name>, <name><surname>Kumar</surname><given-names>S</given-names></name>, <name><surname>Guleria</surname><given-names>K</given-names></name>. <article-title>Outbreak trends of CoronaVirus (COVID-19) in India: A Prediction</article-title>. <source>Disaster Med Public Health Prep</source>. <year>2020</year>; p. <fpage>1</fpage>–<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1017/dmp.2020.115</pub-id>
<?supplied-pmid 32317044?><pub-id pub-id-type="pmid">32317044</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref088">
                <label>88</label>
                <mixed-citation publication-type="journal"><name><surname>Ayyoubzadeh</surname><given-names>SM</given-names></name>, <name><surname>Ayyoubzadeh</surname><given-names>SM</given-names></name>, <name><surname>Zahedi</surname><given-names>H</given-names></name>, <name><surname>Ahmadi</surname><given-names>M</given-names></name>, <name><surname>Kalhori</surname><given-names>SRN</given-names></name>. <article-title>Predicting COVID-19 Incidence Through Analysis of Google Trends Data in Iran: Data Mining and Deep Learning Pilot Study</article-title>. <source>JMIR Public Health Surveill</source>. <year>2020</year>;<volume>6</volume>(<issue>2</issue>):<fpage>e18828</fpage>. <pub-id pub-id-type="doi">10.2196/18828</pub-id><?supplied-pmid 32234709?><pub-id pub-id-type="pmid">32234709</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref089">
                <label>89</label>
                <mixed-citation publication-type="other">COVID I, Murray CJ, et al. Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref090">
                <label>90</label>
                <mixed-citation publication-type="other">Woody S, Tec MG, Dahan M, Gaither K, Fox S, Meyers LA, et al. Projections for first-wave COVID-19 deaths across the US using social-distancing measures derived from mobile phones. medRxiv. 2020;</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref091">
                <label>91</label>
                <mixed-citation publication-type="journal"><name><surname>Flaxman</surname><given-names>S</given-names></name>, <name><surname>Mishra</surname><given-names>S</given-names></name>, <name><surname>Gandy</surname><given-names>A</given-names></name>, <name><surname>Unwin</surname><given-names>HJT</given-names></name>, <name><surname>Mellan</surname><given-names>TA</given-names></name>, <name><surname>Coupland</surname><given-names>H</given-names></name>, <etal>et al</etal>. <article-title>Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe</article-title>. <source>Nature</source>. <year>2020</year>; p. <fpage>1</fpage>–<lpage>5</lpage>. <?supplied-pmid 32512579?><pub-id pub-id-type="pmid">32512579</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref092">
                <label>92</label>
                <mixed-citation publication-type="journal"><name><surname>Yuan</surname><given-names>X</given-names></name>, <name><surname>Xu</surname><given-names>J</given-names></name>, <name><surname>Hussain</surname><given-names>S</given-names></name>, <name><surname>Wang</surname><given-names>H</given-names></name>, <name><surname>Gao</surname><given-names>N</given-names></name>, <name><surname>Zhang</surname><given-names>L</given-names></name>. <article-title>Trends and Prediction in Daily New Cases and Deaths of COVID-19 in the United States: An Internet Search-Interest Based Model</article-title>. <source>Explor Res Hypothesis Med</source>. <year>2020</year>;<volume>5</volume>(<issue>2</issue>):<fpage>1</fpage>. <pub-id pub-id-type="doi">10.14218/ERHM.2020.00023</pub-id><?supplied-pmid 32348380?><pub-id pub-id-type="pmid">32348380</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref093">
                <label>93</label>
                <mixed-citation publication-type="journal"><name><surname>Qin</surname><given-names>L</given-names></name>, <name><surname>Sun</surname><given-names>Q</given-names></name>, <name><surname>Wang</surname><given-names>Y</given-names></name>, <name><surname>Wu</surname><given-names>KF</given-names></name>, <name><surname>Chen</surname><given-names>M</given-names></name>, <name><surname>Shia</surname><given-names>BC</given-names></name>, <etal>et al</etal>. <article-title>Prediction of Number of Cases of 2019 Novel Coronavirus (COVID-19) Using Social Media Search Index</article-title>. <source>Int J Environ Res Public Health</source>. <year>2020</year>;<volume>17</volume>(<issue>7</issue>):<fpage>2365</fpage>. <pub-id pub-id-type="doi">10.3390/ijerph17072365</pub-id><?supplied-pmid 32244425?><pub-id pub-id-type="pmid">32244425</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref094">
                <label>94</label>
                <mixed-citation publication-type="other">The COVID Tracking Project;. <ext-link ext-link-type="uri" xlink:href="https://github.com/COVID19Tracking/covid-public-api">https://github.com/COVID19Tracking/covid-public-api</ext-link>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref095">
                <label>95</label>
                <mixed-citation publication-type="journal"><name><surname>Oran</surname><given-names>DP</given-names></name>, <name><surname>Topol</surname><given-names>EJ</given-names></name>. <article-title>Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review</article-title>. <source>Annals of Internal Medicine</source>. <year>2020</year>;. <pub-id pub-id-type="doi">10.7326/M20-3012</pub-id><?supplied-pmid 32491919?><pub-id pub-id-type="pmid">32491919</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref096">
                <label>96</label>
                <mixed-citation publication-type="other">Shear MD, Goodnough A, Kaplan S, Fink S, Thomas K, Weiland N. The lost month: how a failure to test blinded the US to Covid-19. The New York Times. 2020.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref097">
                <label>97</label>
                <mixed-citation publication-type="book"><name><surname>Ramsay</surname><given-names>JO</given-names></name>, <name><surname>Silverman</surname><given-names>BW</given-names></name>. <source>Applied functional data analysis: methods and case studies</source>. <publisher-name>Springer</publisher-name>; <year>2007</year>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref098">
                <label>98</label>
                <mixed-citation publication-type="other">Su YS, Yajima M. R2jags: Using R to run ‘JAGS’; 2015. Available from: <ext-link ext-link-type="uri" xlink:href="https://CRAN.R-project.org/package=R2jags">https://CRAN.R-project.org/package=R2jags</ext-link>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref099">
                <label>99</label>
                <mixed-citation publication-type="other">Caruana R, Niculescu-Mizil A. An empirical comparison of supervised learning algorithms. In: Proceedings of the 23rd international conference on Machine learning; 2006. p. 161–168.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref100">
                <label>100</label>
                <mixed-citation publication-type="journal"><name><surname>Breiman</surname><given-names>L</given-names></name>. <article-title>Random forests</article-title>. <source>Machine Learning</source>. <year>2001</year>;<volume>45</volume>(<issue>1</issue>):<fpage>5</fpage>–<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1023/A:1010933404324</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref101">
                <label>101</label>
                <mixed-citation publication-type="journal"><name><surname>Liaw</surname><given-names>A</given-names></name>, <name><surname>Wiener</surname><given-names>M</given-names></name>. <article-title>Classification and regression by randomForest</article-title>. <source>R News</source>. <year>2002</year>;<volume>2</volume>(<issue>3</issue>):<fpage>18</fpage>–<lpage>22</lpage>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref102">
                <label>102</label>
                <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>H</given-names></name>, <name><surname>Zimmerman</surname><given-names>J</given-names></name>, <name><surname>Nettleton</surname><given-names>D</given-names></name>, <name><surname>Nordman</surname><given-names>DJ</given-names></name>. <article-title>Random forest prediction intervals</article-title>. <source>The American Statistician</source>. <year>2019</year>; p. <fpage>1</fpage>–<lpage>15</lpage>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref103">
                <label>103</label>
                <mixed-citation publication-type="other">Zhang H. Random Forest Prediction Intervals; 2018. <ext-link ext-link-type="uri" xlink:href="https://github.com/haozhestat/RFIntervals">https://github.com/haozhestat/RFIntervals</ext-link>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref104">
                <label>104</label>
                <mixed-citation publication-type="journal"><name><surname>Roberts</surname><given-names>DR</given-names></name>, <name><surname>Bahn</surname><given-names>V</given-names></name>, <name><surname>Ciuti</surname><given-names>S</given-names></name>, <name><surname>Boyce</surname><given-names>MS</given-names></name>, <name><surname>Elith</surname><given-names>J</given-names></name>, <name><surname>Guillera-Arroita</surname><given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Cross-validation strategies for data with temporal, spatial, hierarchical, or phylogenetic structure</article-title>. <source>Ecography</source>. <year>2017</year>;<volume>40</volume>(<issue>8</issue>):<fpage>913</fpage>–<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1111/ecog.02881</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref105">
                <label>105</label>
                <mixed-citation publication-type="journal"><name><surname>Soetaert</surname><given-names>K</given-names></name>, <name><surname>Petzoldt</surname><given-names>T</given-names></name>, <name><surname>Setzer</surname><given-names>RW</given-names></name>. <article-title>Solving differential equations in R: package deSolve</article-title>. <source>J Stat Softw</source>. <year>2010</year>;<volume>33</volume>(<issue>9</issue>):<fpage>1</fpage>–<lpage>25</lpage>. <pub-id pub-id-type="doi">10.18637/jss.v033.i09</pub-id><pub-id pub-id-type="pmid">20808728</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref106">
                <label>106</label>
                <mixed-citation publication-type="book"><collab>R Core Team</collab>. <source>R: A Language and Environment for Statistical Computing</source>; <year>2019</year>. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.R-project.org/">https://www.R-project.org/</ext-link>.</mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref107">
                <label>107</label>
                <mixed-citation publication-type="journal"><name><surname>Wölfel</surname><given-names>R</given-names></name>, <name><surname>Corman</surname><given-names>VM</given-names></name>, <name><surname>Guggemos</surname><given-names>W</given-names></name>, <name><surname>Seilmaier</surname><given-names>M</given-names></name>, <name><surname>Zange</surname><given-names>S</given-names></name>, <name><surname>Müller</surname><given-names>MA</given-names></name>, <etal>et al</etal>. <article-title>Virological assessment of hospitalized patients with COVID-2019</article-title>. <source>Nature</source>. <year>2020</year>;<volume>581</volume>(<issue>7809</issue>):<fpage>465</fpage>–<lpage>469</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2196-x</pub-id>
<?supplied-pmid 32235945?><pub-id pub-id-type="pmid">32235945</pub-id></mixed-citation>
              </ref>
              <ref id="pcbi.1008837.ref108">
                <label>108</label>
                <mixed-citation publication-type="journal"><name><surname>Hyndman</surname><given-names>RJ</given-names></name>, <name><surname>Koehler</surname><given-names>AB</given-names></name>. <article-title>Another look at measures of forecast accuracy</article-title>. <source>Int J Forecast</source>. <year>2006</year>;<volume>22</volume>(<issue>4</issue>):<fpage>679</fpage>–<lpage>688</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijforecast.2006.03.001</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
          <sub-article id="pcbi.1008837.r001" article-type="aggregated-review-documents">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pcbi.1008837.r001</article-id>
              <title-group>
                <article-title>Decision Letter 0</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pitzer</surname>
                    <given-names>Virginia E.</given-names>
                  </name>
                  <role>Deputy Editor</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Althouse</surname>
                    <given-names>Benjamin Muir</given-names>
                  </name>
                  <role>Associate Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Pitzer, Althouse</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Pitzer, Althouse</copyright-holder>
                <license>
                  <ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article id="rel-obj001" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008837" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>0</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">1 Jul 2020</named-content>
              </p>
              <p>Dear Mr. Watson,</p>
              <p>Thank you very much for submitting your manuscript "Fusing a Bayesian case velocity model with random forest for predicting COVID-19 in the U.S." for consideration at PLOS Computational Biology.</p>
              <p>As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.</p>
              <p>We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.</p>
              <p>When you are ready to resubmit, please upload the following:</p>
              <p>[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.</p>
              <p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p>
              <p>Important additional instructions are given below your reviewer comments.</p>
              <p>Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.</p>
              <p>Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
              <p>Sincerely,</p>
              <p>Benjamin Althouse</p>
              <p>Associate Editor</p>
              <p>PLOS Computational Biology</p>
              <p>Virginia Pitzer</p>
              <p>Deputy Editor</p>
              <p>PLOS Computational Biology</p>
              <p>***********************</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Authors:</bold>
              </p>
              <p>
                <bold>Please note here if the review is uploaded as an attachment.</bold>
              </p>
              <p>Reviewer #1: The method proposed by Watson and colleagues has various compelling aspects--it combines a Bayesian hierarchical model, compartmental SIRD model and a machine learning methods for forecasting into the future--with the goal of accurately forecasting COVID-19-confirmed cases and deaths. The model is meant to predict so-called “case velocity” and yields forecasting intervals, which is very important, and I am not concerned by the fact that they cannot be formally interpreted as posterior uncertainty intervals. Overall, while I think that the approach taken is a sensible one, there are a number of concerns and suggestions that I would make to the authors towards a much stronger revised version of the paper.</p>
              <p>1. Each of the modeling components of your method has its strengths and weaknesses. The strengths of the methods are not explained or utilized to the fullest degree possible; the weaknesses should be more fully explored through sensitivity analyses. I will taken each component in turn.  a. The strengths of the SIRD model are that it is mechanistic, however this is not exploited to, e.g. simulate various scenarios for opening up, etc. Estimates of the rate of transmission by state are also of particular importance—and can be compared to the estimates derived by other methods—but it does not seem that these are explicited reported anywhere unless I have missed them. A limitation of the SIRD model is that it requires setting initial conditions—your discussion on lines 120-123 should be expanded to understand the sensitivity our your approach to these choices. I am not an expert on SIRD, but I imagine as with any mechanistic model there are potentially many sensitivities to somewhat arbitrary choices. These should be explored.  b. The strengths of the hierarchical model are that it gives interpretable state-level estimates for parameters that policymakers care about. I saw little discussion of the posteriors over these parameters, how they compare to previous studies, etc. There are of course limitations here, which could be discussed as well, but I don’t expect this to drastically change your overall results in any way.  c. The strengths of the random forest model are that it is an effective black box machine learning method that can use whatever covariates you throw at it. The limitations are that it is only partially interpretable—variable importance is useful, but does not give effect sizes. It would be very useful to know if a simpler, interpretable method were able to give reasonable results. Two ideas that you may have considered and would be worth a quantitative comparison: time series methods (e.g. autoregressive or exponential smoothing); carrying forward the SIRD model</p>
              <p>2. Your SIRD formulation is non-standard, as far as I am aware. I would have expected theta(t) to appear in the equation for dI/dt. Is your Eq (2) somehow equivalent to the following, which is what I expected?</p>
              <p>dS/dt = -xi(t)</p>
              <p>dI/dt = xi(t) - rho I (t) - theta(t)</p>
              <p>dR/dt = rho I(t)</p>
              <p>dD/dt = theta(t)</p>
              <p>3. I am not totally convinced by how the three parts of your model fit together.</p>
              <p>a) It would be nice if there was more integration between the pieces—there are methods for Bayesian inference of SIR models using modern probabilistic programming languages like Stan. Could you have combined the hierarchical model with the SIRD model? I will not claim this is easy as I have not tried, but it would be good to discuss this.</p>
              <p>b) the discussion surrounding Eqs 8-9 says that c_i is not identifiable and you find it by minimizing MSE, but I am not sure what c_i is and would like to know how well this minimization works and what effect it has. I’m also not convinced that this yields a posterior distribution for c_i, but given that ultimately you are not doing Bayesian inference it probably doesn’t matter.</p>
              <p>c) I am trying to make sense of sampling rho ~ Normal(14,1). Given your formulation of SIRD (which I questioned earlier), rho is the probability of transitioning from Infection to either Recovered or Death. You should provide citations to justify a mean of 14. I am familiar with estimates of the infection-to-onset distribution and the onset-to-death distribution, but this is neither of those.</p>
              <p>d) The random forest component of your approach is meant to give an estimate of the transition from infection to death, but I am not convinced that this is what it is truly doing due to my concerns about the reliability of case reports (see below). To understand and diagnose this concern, it would be helpful to compare your random forest model’s predictions of the number of people transitioning from I to D to published estimates of the infection fatality rate. Admittedly, I’m a little unclear on whether/how these can be directly compared, so if this is impossible it would be useful to know why as I see this as a limitation of your model, despite it having an underlying epidemiological component. Returning to the infection-to-death distribution, estimates put this at around 2 to 3 weeks, so it seems like your random forest model should include data that is more than 14 days in the past. (In fact, I don’t see what is the relevance of data t-1 or t-2!) The data limitations you mention can now be alleviated as I imagine you will want to refit your model on the most recently available data.</p>
              <p>4. The reliance on cases concerns me with respect to accurately modeling COVID-19 due to the widespread, undetected community transmission in the early period of the USA epidemic, the changing testing strategies and availability during the course of the USA epidemic, and the large fraction of asymptomatic cases throughout. Attempts have been made to adjust for some of this (e.g. Hsiang et al, Nature 2020) but I am not convinced that this is truly possible, which is why my group has focused on modeling deaths instead of cases (Flaxman et al, Nature 2020). This all leads to another important concern, which is that your overall goal is predict case velocity. I can see this as potentially a useful goal, especially in the post-stay-at-home phase of the epidemic and the possible second wave phase of the epidemic, but would like to see more justification for this goal. I am still not convinced that case reporting is good enough that we should rely on it—if it is not good enough, then why is it your goal to predict it? Said differently, perhaps you wish to predict the true rate of cases; but then what, exactly is a case? The true thing that you could try to predict is infections. I am certainly not saying you need to take the approach of our group, but for work in this vein see Flaxman et al Nature 2020 and our US report: <ext-link ext-link-type="uri" xlink:href="https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-05-28-COVID19-Report-23-version2.pdf">https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-05-28-COVID19-Report-23-version2.pdf</ext-link></p>
              <p>5. If the overall goal is accurate forecasting of case velocity, then I think there are two pieces missing:</p>
              <p>a. A more indepth and exhaustive approach to evaluating your forecasting method—this could, e.g. include 1, 3, 7, and 21 day ahead forecasting, starting from an early period in the epidemic and carried forwards with subsequently more days of data included. Various metrics could be included, including MAE/coverage/CRPS.</p>
              <p>b. A justification for including the SIRD and hierarchical modelling framework; would a black box machine learning method on its own give at least as good performance as your method? If so, what is it that your model reveals about the spread of the disease that a black box model on its own would not?  </p>
              <p>6. Source code to replicate every part of your analysis should already be made available. In this world of falling public trust in scientists and policymakers, it is critically important to strive for replicable and reproducible analyses. The effort spent is entirely worth it due to the benefit that comes from having more pairs of eyes inspecting your assumptions, your model, your data pipeline, and so on.</p>
              <p>7. Speaking of data, I may have missed it but do you use JHU or NYT data? We found that JHU data was on the whole reliable, though it suffers from various inconsistencies, and it is important to point out that this data is usually date of report for deaths, rather than date of death. (The JHU data was not reliable for New York State, and for this we used NYT.)</p>
              <p>8. A minor issue, and I am sorry to quibble about this but it is of course the part I know best: I do not agree with your characterisation of the Flaxman et al model as a serial growth model (honestly I’m not sure what this means so maybe I’m wrong!), nor is the description of “weights being sampled from a probability distribution” an accurate description of our Bayesian inference method (perhaps it is an accurate description of the other methods). Compare, for example, our fully Bayesian MCMC scheme to the number of infections on a given day (which derives from a discrete time convolution using the generation distribution multiplied by the time-varying reproduction number R) to your scheme for introducing stochasticity into your SIRD model by sampling rho which could accurately be described as weights being sampled from a probability distribution.</p>
              <p>Signed,</p>
              <p> Seth Flaxman</p>
              <p>Reviewer #2: please see attached</p>
              <p>**********</p>
              <p>
                <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
              </p>
              <p>Large-scale datasets should be made available via a public repository as described in the <italic>PLOS Computational Biology</italic>
<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/data-availability">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
              <p>Reviewer #1: <bold>No: </bold>see comments about reproducibility in the review</p>
              <p>Reviewer #2: Yes</p>
              <p>**********</p>
              <p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
              <p>Reviewer #1: <bold>Yes: </bold>Seth Flaxman</p>
              <p>Reviewer #2: <bold>Yes: </bold>Spencer Woody</p>
              <p>
                <underline>Figure Files:</underline>
              </p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <underline><ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/" xlink:type="simple">https://pacev2.apexcovantage.com</ext-link></underline>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <underline><email xlink:type="simple">figures@plos.org</email></underline>.</p>
              <p>
                <underline>Data Requirements:</underline>
              </p>
              <p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: <ext-link ext-link-type="uri" xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p>
              <p>
                <underline>Reproducibility:</underline>
              </p>
              <p>To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions, please see <underline><ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plospathogens/s/submission-guidelines" xlink:type="simple">http://journals.plos.org/compbiol/s/submission-guidelines#loc-materials-and-methods</ext-link></underline></p>
            </body>
          </sub-article>
          <sub-article id="pcbi.1008837.r002" article-type="author-comment">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pcbi.1008837.r002</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 0</article-title>
              </title-group>
              <related-article id="rel-obj002" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008837" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">20 Sep 2020</named-content>
              </p>
              <supplementary-material content-type="local-data" id="pcbi.1008837.s005">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers.pdf</named-content></p>
                </caption>
                <media xlink:href="pcbi.1008837.s005.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article id="pcbi.1008837.r003" article-type="aggregated-review-documents">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pcbi.1008837.r003</article-id>
              <title-group>
                <article-title>Decision Letter 1</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pitzer</surname>
                    <given-names>Virginia E.</given-names>
                  </name>
                  <role>Deputy Editor</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Althouse</surname>
                    <given-names>Benjamin Muir</given-names>
                  </name>
                  <role>Associate Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Pitzer, Althouse</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Pitzer, Althouse</copyright-holder>
                <license>
                  <ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article id="rel-obj003" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008837" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>1</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">12 Nov 2020</named-content>
              </p>
              <p>Dear Mr. Watson,</p>
              <p>Thank you very much for submitting your manuscript "Fusing a Bayesian velocity model with random forest for predicting COVID-19 in the U.S." for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.</p>
              <p>Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. </p>
              <p>When you are ready to resubmit, please upload the following:</p>
              <p>[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out</p>
              <p>[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).</p>
              <p>Important additional instructions are given below your reviewer comments.</p>
              <p>Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.</p>
              <p>Sincerely,</p>
              <p>Benjamin Muir Althouse</p>
              <p>Associate Editor</p>
              <p>PLOS Computational Biology</p>
              <p>Virginia Pitzer</p>
              <p>Deputy Editor</p>
              <p>PLOS Computational Biology</p>
              <p>***********************</p>
              <p>A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact <email>ploscompbiol@plos.org</email> immediately:</p>
              <p>[LINK]</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Authors:</bold>
              </p>
              <p>
                <bold>Please note here if the review is uploaded as an attachment.</bold>
              </p>
              <p>Reviewer #1: Dear authors,</p>
              <p>Thank you for your comprehensive response and set of revisions. In particular, your clarification and focus on "case velocity" has definitely sharpened the paper and its goals.</p>
              <p>There are a few final issues that I think you should address to strengthen your paper and its support for the new method you have proposed.</p>
              <p>1) I still think it would be very worthwhile to address this point: "The random forest component of your approach is meant to give an estimate of the transition from infection to death, but I am not convinced that this is</p>
              <p>what it is truly doing due to my concerns about the reliability of case reports (see below).To understand and diagnose this concern, it would be helpful to compare your random forest model’s predictions of the number of people transitioning from I to D to published estimates of the infection fatality rate." If helpful, a meta-analysis on IFR is now available <ext-link ext-link-type="uri" xlink:href="https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-IFR/">https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-IFR/</ext-link></p>
              <p>2) You write: "The parameters of the velocity model are not directly comparable to the transmission rate at the heart of more traditional compartmental models". This clarification makes sense to me, but I do still wonder if you could include some direct comparisons to help the reader get a handle on how velocity works, by comparing it to more widely used (and I would argue better understood) quantities such as: the reproduction number, growth rate, or doubling time. Perhaps, for example, you could forward simulate from your model and then empirically calculate the doubling time?</p>
              <p>3) Your points beginning "We agree with this characterization of the strengths and limitations of random forest." make sense to me; thank you for the clarification. I would quibble with this part, however, "It may be possible to construct a time series model that rivals the predictive performance of random forest for our purposes, but we are doubtful, and devising such a model would be a challenging project in its own right and beyond the scope of the</p>
              <p>current work." Since your focus is on predicting one day ahead, I really think it would be helpful for you to include a very simple baseline comparison, such as an autoregressive model, trained separately for each state, or even a no change / constant model. If your model is significantly better than this model, great; if it is competitive, that is fine as well, as you have persuasively argued that there is something to be gained by focusing on velocity rather than simply predicting case counts.</p>
              <p>-Seth Flaxman</p>
              <p>Reviewer #2: Please see attached comments.</p>
              <p>**********</p>
              <p>
                <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
              </p>
              <p>Large-scale datasets should be made available via a public repository as described in the <italic>PLOS Computational Biology</italic>
<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/data-availability">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
              <p>Reviewer #1: None</p>
              <p>Reviewer #2: None</p>
              <p>**********</p>
              <p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
              <p>Reviewer #1: <bold>Yes: </bold>Seth Flaxman</p>
              <p>Reviewer #2: <bold>Yes: </bold>Spencer Woody</p>
              <p>
                <underline>Figure Files:</underline>
              </p>
              <p>While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, <underline><ext-link ext-link-type="uri" xlink:href="https://pacev2.apexcovantage.com/" xlink:type="simple">https://pacev2.apexcovantage.com</ext-link></underline>. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at <underline><email xlink:type="simple">figures@plos.org</email></underline>.</p>
              <p>
                <underline>Data Requirements:</underline>
              </p>
              <p>Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: <ext-link ext-link-type="uri" xlink:href="http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5">http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5</ext-link>.</p>
              <p>
                <underline>Reproducibility:</underline>
              </p>
              <p>To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see <underline><ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/plospathogens/s/submission-guidelines" xlink:type="simple">http://journals.plos.org/ploscompbiol/s/submission-guidelines#loc-materials-and-methods</ext-link></underline></p>
              <supplementary-material content-type="local-data" id="pcbi.1008837.s006">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">PCOMPBIOL-D-20-00822R1-review.pdf</named-content></p>
                </caption>
                <media xlink:href="pcbi.1008837.s006.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article id="pcbi.1008837.r004" article-type="author-comment">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pcbi.1008837.r004</article-id>
              <title-group>
                <article-title>Author response to Decision Letter 1</article-title>
              </title-group>
              <related-article id="rel-obj004" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008837" related-article-type="editor-report"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>2</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="author-response-date">12 Jan 2021</named-content>
              </p>
              <supplementary-material content-type="local-data" id="pcbi.1008837.s007">
                <label>Attachment</label>
                <caption>
                  <p>Submitted filename: <named-content content-type="submitted-filename">Response to Reviewers 2nd Round.pdf</named-content></p>
                </caption>
                <media xlink:href="pcbi.1008837.s007.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </body>
          </sub-article>
          <sub-article id="pcbi.1008837.r005" article-type="aggregated-review-documents">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pcbi.1008837.r005</article-id>
              <title-group>
                <article-title>Decision Letter 2</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pitzer</surname>
                    <given-names>Virginia E.</given-names>
                  </name>
                  <role>Deputy Editor-in-Chief</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Althouse</surname>
                    <given-names>Benjamin Muir</given-names>
                  </name>
                  <role>Associate Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Pitzer, Althouse</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Pitzer, Althouse</copyright-holder>
                <license>
                  <ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article id="rel-obj005" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008837" related-article-type="reviewed-article"/>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>Submission Version</meta-name>
                  <meta-value>2</meta-value>
                </custom-meta>
              </custom-meta-group>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">26 Feb 2021</named-content>
              </p>
              <p>Dear Mr. Watson,</p>
              <p>We are pleased to inform you that your manuscript 'Pandemic velocity: forecasting COVID-19 in the US with a machine learning &amp; Bayesian time series compartmental model' has been provisionally accepted for publication in PLOS Computational Biology.</p>
              <p>Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.</p>
              <p>Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.</p>
              <p>IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.</p>
              <p>Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.</p>
              <p>Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. </p>
              <p>Best regards,</p>
              <p>Benjamin Muir Althouse</p>
              <p>Associate Editor</p>
              <p>PLOS Computational Biology</p>
              <p>Virginia Pitzer</p>
              <p>Deputy Editor-in-Chief</p>
              <p>PLOS Computational Biology</p>
              <p>***********************************************************</p>
              <p>Reviewer's Responses to Questions</p>
              <p>
                <bold>Comments to the Authors:</bold>
              </p>
              <p>
                <bold>Please note here if the review is uploaded as an attachment.</bold>
              </p>
              <p>Reviewer #1: I appreciate the work you have done to revise the paper and hope that it is published soon!</p>
              <p>**********</p>
              <p>
                <bold>Have all data underlying the figures and results presented in the manuscript been provided?</bold>
              </p>
              <p>Large-scale datasets should be made available via a public repository as described in the <italic>PLOS Computational Biology</italic>
<ext-link ext-link-type="uri" xlink:href="http://journals.plos.org/ploscompbiol/s/data-availability">data availability policy</ext-link>, and numerical data that underlies graphs or summary statistics should be provided in spreadsheet form as supporting information.</p>
              <p>Reviewer #1: Yes</p>
              <p>**********</p>
              <p>PLOS authors have the option to publish the peer review history of their article (<ext-link ext-link-type="uri" xlink:href="https://journals.plos.org/ploscompbiol/s/editorial-and-peer-review-process#loc-peer-review-history">what does this mean?</ext-link>). If published, this will include your full peer review and any attached files.</p>
              <p>If you choose “no”, your identity will remain anonymous but your review may still be made public.</p>
              <p><bold>Do you want your identity to be public for this peer review?</bold> For information about this choice, including consent withdrawal, please see our <ext-link ext-link-type="uri" xlink:href="https://www.plos.org/privacy-policy">Privacy Policy</ext-link>.</p>
              <p>Reviewer #1: <bold>Yes: </bold>Seth Flaxman</p>
            </body>
          </sub-article>
          <sub-article id="pcbi.1008837.r006" article-type="editor-report">
            <front-stub>
              <article-id pub-id-type="doi">10.1371/journal.pcbi.1008837.r006</article-id>
              <title-group>
                <article-title>Acceptance letter</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Pitzer</surname>
                    <given-names>Virginia E.</given-names>
                  </name>
                  <role>Deputy Editor-in-Chief</role>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Althouse</surname>
                    <given-names>Benjamin Muir</given-names>
                  </name>
                  <role>Associate Editor</role>
                </contrib>
              </contrib-group>
              <permissions>
                <copyright-statement>© 2021 Pitzer, Althouse</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Pitzer, Althouse</copyright-holder>
                <license>
                  <ali:license_ref specific-use="pmc" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
                </license>
              </permissions>
              <related-article id="rel-obj006" ext-link-type="doi" xlink:href="10.1371/journal.pcbi.1008837" related-article-type="reviewed-article"/>
            </front-stub>
            <body>
              <p>
                <named-content content-type="letter-date">25 Mar 2021</named-content>
              </p>
              <p>PCOMPBIOL-D-20-00822R2 </p>
              <p>Pandemic velocity: forecasting COVID-19 in the US with a machine learning &amp; Bayesian time series compartmental model</p>
              <p>Dear Dr Watson,</p>
              <p>I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.</p>
              <p>The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. </p>
              <p>Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.</p>
              <p>Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work! </p>
              <p>With kind regards,</p>
              <p>Katalin Szabo</p>
              <p>PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom <email>ploscompbiol@plos.org</email> | Phone +44 (0) 1223-442824 | <ext-link ext-link-type="uri" xlink:href="http://ploscompbiol.org">ploscompbiol.org</ext-link> | @PLOSCompBiol</p>
            </body>
          </sub-article>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
